Expression	O
of	O
Mad1	B-protein
in	O
T	B-cell_type
cells	I-cell_type
leads	O
to	O
reduced	O
thymic	O
cellularity	O
and	O
impaired	O
mitogen-induced	O
proliferation	O
.	O

To	O
investigate	O
Mad1	B-protein
function	O
in	O
vivo	O
,	O
transgenic	O
mice	O
were	O
generated	O
that	O
express	O
a	O
Mad1	B-DNA
transgene	I-DNA
in	O
T	B-cell_type
lineage	I-cell_type
cells	I-cell_type
under	O
the	O
control	O
of	O
the	O
proximal	B-DNA
lck	I-DNA
promoter	I-DNA
.	O

Thymus	O
size	O
in	O
lck-Mad1	O
transgenic	O
mice	O
is	O
drastically	O
reduced	O
although	O
representation	O
of	O
the	O
various	O
thymocyte	B-cell_type
sub	I-cell_type
populations	I-cell_type
appears	O
normal	O
.	O

To	O
investigate	O
more	O
closely	O
any	O
effects	O
of	O
Mad1	O
expression	O
on	O
thymocytes	B-cell_type
,	O
we	O
examined	O
thymic	O
selection	O
using	O
MHC	O
class	O
I-restricted	O
H-Y-TCR	O
transgenic	O
mice	O
.	O

Mad1	O
expression	O
in	O
vivo	O
reduces	O
the	O
efficiency	O
of	O
positive	O
selection	O
.	O

Furthermore	O
,	O
thymocytes	B-cell_type
and	O
splenic	B-cell_type
T	I-cell_type
cells	I-cell_type
from	O
lck-Mad1	O
transgenic	O
mice	O
display	O
a	O
profound	O
proliferative	O
defect	O
in	O
response	O
to	O
activation	O
with	O
either	O
PMA/Ionomycin	O
or	O
immobilized	B-protein
anti-CD3/CD28	I-protein
antibody	I-protein
.	O

This	O
proliferative	O
defect	O
is	O
not	O
reversed	O
by	O
addition	O
of	O
exogenous	B-protein
IL-2	I-protein
and	O
is	O
p53-independent	O
.	O

The	O
growth	O
inhibition	O
caused	O
by	O
Mad1	B-protein
is	O
overcome	O
by	O
expression	O
of	O
active	B-protein
c-Myc	I-protein
.	O

a	NULL
Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
1164-1175	NULL
©	NULL
2001	NULL
Nature	NULL
Publishing	NULL
Group	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/01	NULL
$	NULL
15.00	NULL
www.nature.com/onc	NULL
Expression	NULL
of	NULL
Mad1	NULL
in	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
reduced	NULL
thymic	NULL
cellularity	NULL
and	NULL
impaired	NULL
mitogen-induced	NULL
proliferation	NULL
Bettina	NULL
Rudolph	NULL
``	NULL
,	NULL
Anne-Odile	NULL
Hueber	NULL
``	NULL
``	NULL
and	NULL
Gerard	NULL
I	NULL
Evan*'*	NULL
'Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
PO	NULL
Box	NULL
123	NULL
,	NULL
44	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
WC2A4	NULL
3PX	NULL
,	NULL
UK	NULL
To	NULL
investigate	NULL
Mad1	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
transgenic	NULL
mice	NULL
were	NULL
generated	NULL
that	NULL
express	NULL
a	NULL
Madl	NULL
transgene	NULL
in	NULL
T	NULL
lineage	NULL
cells	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
proximal	NULL
[	NULL
Ick	NULL
promoter	NULL
.	NULL

Thymus	NULL
size	NULL
in	NULL
ick-Mad1	NULL
transgenic	NULL
mice	NULL
is	NULL
drastically	NULL
reduced	NULL
although	NULL
representation	NULL
of	NULL
the	NULL
various	NULL
thymocyte	NULL
sub	NULL
populations	NULL
appears	NULL
normal	NULL
.	NULL

To	NULL
investigate	NULL
more	NULL
closely	NULL
any	NULL
effects	NULL
of	NULL
Mad1	NULL
expression	NULL
on	NULL
thymocytes	NULL
,	NULL
we	NULL
examined	NULL
thymic	NULL
selection	NULL
using	NULL
MHC	NULL
class	NULL
TI-restricted	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
.	NULL

Madl	NULL
expression	NULL
in	NULL
vivo	NULL
reduces	NULL
the	NULL
efficiency	NULL
of	NULL
positive	NULL
selection	NULL
.	NULL

Furthermore	NULL
,	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
i/ck-Mad1	NULL
transgenic	NULL
mice	NULL
display	NULL
a	NULL
profound	NULL
proliferative	NULL
defect	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
with	NULL
either	NULL
PMA/Ionomycin	NULL
or	NULL
immobilized	NULL
anti-CD3/CD28	NULL
antibody	NULL
.	NULL

This	NULL
proliferative	NULL
defect	NULL
is	NULL
not	NULL
reversed	NULL
by	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
and	NULL
is	NULL
p53-independent	NULL
.	NULL

The	NULL
growth	NULL
inhibition	NULL
caused	NULL
by	NULL
Madl	NULL
is	NULL
overcome	NULL
by	NULL
expression	NULL
of	NULL
active	NULL
c-Myc	NULL
.	NULL

Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
1164-1175	NULL
.	NULL

Keywords	NULL
:	NULL
Myc	NULL
;	NULL
Mad	NULL
;	NULL
oncogene	NULL
;	NULL
cell	NULL
cycle	NULL
;	NULL
lympho-cyte	NULL
;	NULL
tumor	NULL
suppressor	NULL
Introduction	NULL
Madl	NULL
is	NULL
one	NULL
of	NULL
a	NULL
family	NULL
of	NULL
three	NULL
known	NULL
bHLHLZip	NULL
proteins	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Madl	NULL
homodimerizes	NULL
poorly	NULL
but	NULL
interacts	NULL
with	NULL
Max	NULL
to	NULL
form	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
heterodimer	NULL
.	NULL

The	NULL
bHLHLZip	NULL
domain	NULL
of	NULL
Madl	NULL
is	NULL
required	NULL
for	NULL
both	NULL
heterodimeriza-tion	NULL
with	NULL
Max	NULL
and	NULL
its	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
(	NULL
Blackwell	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
Mad1/Max	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
same	NULL
E	NULL
box	NULL
motif	NULL
as	NULL
Myc/Max	NULL
heterodimers	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
Myc/Max	NULL
,	NULL
Mad1/Max	NULL
complexes	NULL
function	NULL
as	NULL
transcriptional	NULL
repressors	NULL
(	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
co-repressors	NULL
mSin3A/mSin3B	NULL
and	NULL
the	NULL
mammalian	NULL
histone	NULL
acetylases	NULL
HDAC	NULL
and	NULL
HDAC2	NULL
.	NULL

Madl	NULL
association	NULL
with	NULL
mSin3A/	NULL
mSin3B/HDAC	NULL
requires	NULL
the	NULL
N-terminal	NULL
25	NULL
residues	NULL
of	NULL
Madl	NULL
.	NULL

Point	NULL
mutations	NULL
in	NULL
this	NULL
region	NULL
eliminate	NULL
not	NULL
*Correspondence	NULL
:	NULL
GI	NULL
Evan	NULL
Current	NULL
addresses	NULL
:	NULL
*DeveloGen	NULL
AG	NULL
,	NULL
Rudolf-Wissell-Str	NULL
.	NULL

28	NULL
,	NULL
D	NULL
37079	NULL
Gottingen	NULL
;	NULL
'Centre	NULL
d'Immunologie	NULL
,	NULL
INSERM-CNRS	NULL
de	NULL
Marseille-Luminy	NULL
,	NULL
Case	NULL
906	NULL
,	NULL
F	NULL
-	NULL
13288	NULL
Marseille	NULL
Cedex	NULL
9	NULL
,	NULL
France	NULL
;	NULL
*UCSF	NULL
Cancer	NULL
Center	NULL
and	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
2340	NULL
Sutter	NULL
Street	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143-0875	NULL
,	NULL
USA	NULL
Received	NULL
12	NULL
October	NULL
2000	NULL
;	NULL
revised	NULL
12	NULL
December	NULL
2000	NULL
;	NULL
accepted	NULL
19	NULL
December	NULL
2000	NULL
only	NULL
the	NULL
interaction	NULL
between	NULL
Mad1	NULL
and	NULL
mSin3A¥/Sin3B/	NULL
HDAC	NULL
but	NULL
also	NULL
block	NULL
Madl	NULL
transcriptional	NULL
repression	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
Madl	NULL
represses	NULL
transcription	NULL
by	NULL
recruiting	NULL
histone	NULL
deacetylases	NULL
to	NULL
target	NULL
sites	NULL
on	NULL
DNA	NULL
(	NULL
for	NULL
review	NULL
:	NULL
Kiermaier	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Madl	NULL
,	NULL
the	NULL
Mad	NULL
protein	NULL
family	NULL
also	NULL
comprises	NULL
Mxi	NULL
(	NULL
Zervos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
Mad3	NULL
and	NULL
Mad4	NULL
(	NULL
Hurlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
specifically	NULL
associate	NULL
with	NULL
Max	NULL
to	NULL
repress	NULL
transcription	NULL
.	NULL

Mad	NULL
proteins	NULL
,	NULL
like	NULL
Myc	NULL
proteins	NULL
,	NULL
are	NULL
short-lived	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
their	NULL
expression	NULL
is	NULL
tightly	NULL
regulated	NULL
during	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
in	NULL
response	NULL
to	NULL
induced	NULL
differentiation	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Zervos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Hurlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Larsson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
Max	NULL
protein	NULL
is	NULL
constitutive	NULL
.	NULL

However	NULL
,	NULL
because	NULL
both	NULL
Myc	NULL
and	NULL
Madl	NULL
compete	NULL
for	NULL
Max	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
access	NULL
of	NULL
Myc	NULL
to	NULL
Max	NULL
is	NULL
profoundly	NULL
dependent	NULL
upon	NULL
expression	NULL
of	NULL
Madl	NULL
(	NULL
and	NULL
vice	NULL
versa	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
Madl1/Max	NULL
complexes	NULL
function	NULL
as	NULL
repressors	NULL
of	NULL
Myc	NULL
activity	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
Madl1/Max	NULL
(	NULL
and	NULL
Mxi/Max	NULL
)	NULL
inhibit	NULL
Myc	NULL
transactivation	NULL
of	NULL
reporter	NULL
plasmid	NULL
constructs	NULL
containing	NULL
the	NULL
Myc	NULL
consensus	NULL
element	NULL
(	NULL
Ayer	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Zervos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Backwood	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
that	NULL
Madl	NULL
suppresses	NULL
Myc	NULL
transforming	NULL
activity	NULL
in	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
(	NULL
Lahoz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
Mad	NULL
proteins	NULL
resides	NULL
solely	NULL
in	NULL
their	NULL
abilities	NULL
to	NULL
antagonize	NULL
Myc	NULL
proteins	NULL
or	NULL
whether	NULL
,	NULL
as	NULL
dominant	NULL
trans-repres-sors	NULL
,	NULL
they	NULL
fulfill	NULL
other	NULL
roles	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
gain	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
biological	NULL
action	NULL
of	NULL
Madl	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
Madl	NULL
transgene	NULL
is	NULL
targeted	NULL
to	NULL
the	NULL
thymus	NULL
,	NULL
a	NULL
tissue	NULL
in	NULL
which	NULL
both	NULL
c-Mye	NULL
and	NULL
Madl	NULL
are	NULL
normally	NULL
expressed	NULL
(	NULL
Broussard-Dichl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Foley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
analysis	NULL
indicates	NULL
that	NULL
different	NULL
members	NULL
of	NULL
the	NULL
Mad	NULL
gene	NULL
family	NULL
are	NULL
expressed	NULL
in	NULL
distinct	NULL
,	NULL
yet	NULL
partially	NULL
overlapping	NULL
patterns	NULL
in	NULL
adult	NULL
thymus	NULL
(	NULL
Queva	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Since	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
play	NULL
such	NULL
crucial	NULL
roles	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
the	NULL
thymus	NULL
offers	NULL
itself	NULL
as	NULL
a	NULL
particularly	NULL
intriguing	NULL
experimental	NULL
system	NULL
in	NULL
which	NULL
to	NULL
examine	NULL
the	NULL
consequences	NULL
of	NULL
manipulating	NULL
the	NULL
Myc/Max/Madl1	NULL
network	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
date	NULL
,	NULL
transgenic	NULL
mouse	NULL
analysis	NULL
of	NULL
the	NULL
Myc/Max/	NULL
Madl	NULL
network	NULL
has	NULL
been	NULL
restricted	NULL
to	NULL
ectopic	NULL
expression	NULL
of	NULL
c-mye	NULL
within	NULL
the	NULL
lymphoid	NULL
compartment	NULL
(	NULL
CD2-c-	NULL
mye	NULL
,	NULL
Thyl-comyc	NULL
,	NULL
Epu-c-myc	NULL
)	NULL
(	NULL
Stewart	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Spanopoulou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Adams	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
all	NULL
such	NULL
cases	NULL
deregulated	NULL
c-myc	NULL
expression	NULL
results	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
tumors	NULL
,	NULL
making	NULL
it	NULL
difficult	NULL
to	NULL
analyse	NULL
normal	NULL
lymphocyte	NULL
differentiation	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

C-mye	NULL
knockout	NULL
mice	NULL
have	NULL
also	NULL
been	NULL
generated	NULL
but	NULL
these	NULL
die	NULL
between	NULL
day	NULL
E9.5	NULL
and	NULL
E10.5	NULL
of	NULL
gestation	NULL
(	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
lymphocyte	NULL
ontogeny	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
consequences	NULL
of	NULL
ectopic	NULL
Mad1	NULL
expression	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
investigated	NULL
and	NULL
although	NULL
Mad1-~-	NULL
have	NULL
been	NULL
generated	NULL
and	NULL
are	NULL
viable	NULL
,	NULL
no	NULL
data	NULL
are	NULL
available	NULL
concerning	NULL
Tcell	NULL
development	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
expression	NULL
of	NULL
a	NULL
Madl	NULL
transgene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
proximal	NULL
/ck	NULL
promoter	NULL
on	NULL
thymocyte	NULL
development	NULL
.	NULL

We	NULL
show	NULL
that	NULL
although	NULL
thymus	NULL
size	NULL
in	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
is	NULL
drastically	NULL
reduced	NULL
,	NULL
general	NULL
representation	NULL
of	NULL
individual	NULL
thymocyte	NULL
sub	NULL
populations	NULL
seems	NULL
overtly	NULL
normal	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
Madl	NULL
expression	NULL
on	NULL
positive	NULL
thymocyte	NULL
selection	NULL
using	NULL
MHC	NULL
class	NULL
TI-restricted	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
.	NULL

This	NULL
analysis	NULL
shows	NULL
that	NULL
Madl	NULL
expression	NULL
reduces	NULL
the	NULL
efficiency	NULL
of	NULL
positive	NULL
selection	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
[	NULL
Ick-Mad	NULL
!	NULL

l	NULL
transgenic	NULL
mice	NULL
display	NULL
a	NULL
profound	NULL
proliferative	NULL
defect	NULL
when	NULL
activated	NULL
with	NULL
PMA/Ionomycin	NULL
or	NULL
anti-CD3/	NULL
CD28	NULL
antibody	NULL
in	NULL
vitro	NULL
.	NULL

Only	NULL
the	NULL
first	NULL
thymocyte	NULL
G0	NULL
S	NULL
transition	NULL
is	NULL
inhibited	NULL
by	NULL
Madl	NULL
expression	NULL
and	NULL
this	NULL
inhibition	NULL
can	NULL
be	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
overcome	NULL
by	NULL
co-expression	NULL
of	NULL
c-Myc	NULL
.	NULL

Results	NULL
Generation	NULL
of	NULL
\ck-Madl1	NULL
transgenic	NULL
mice	NULL
To	NULL
examine	NULL
the	NULL
action	NULL
of	NULL
Madl	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
generated	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
a	NULL
Madl	NULL
transgene	NULL
was	NULL
expressed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
specific	NULL
proximal	NULL
ick	NULL
promoter	NULL
which	NULL
directs	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
to	NULL
thymocytes	NULL
and	NULL
mature	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
Wildin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
transgenic	NULL
construct	NULL
is	NULL
depicted	NULL
in	NULL
Figure	NULL
la	NULL
.	NULL

Construct	NULL
DNA	NULL
was	NULL
injected	NULL
into	NULL
C57BL/	NULL
6x	NULL
CBA	NULL
F1	NULL
embryos	NULL
using	NULL
standard	NULL
techniques	NULL
(	NULL
Brin-ster	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Two	NULL
founder	NULL
lines	NULL
were	NULL
generated	NULL
,	NULL
both	NULL
harbouring	NULL
roughly	NULL
the	NULL
same	NULL
copy	NULL
number	NULL
(	NULL
~10	NULL
copies	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
lines	NULL
behaved	NULL
identically	NULL
and	NULL
are	NULL
therefore	NULL
not	NULL
further	NULL
distinguished	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Mad1	NULL
transgene	NULL
was	NULL
monitored	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
total	NULL
RNA	NULL
and	NULL
a	NULL
human	NULL
Madl	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transgene	NULL
was	NULL
detected	NULL
in	NULL
transgenic	NULL
thymus	NULL
and	NULL
spleen	NULL
tissue	NULL
.	NULL

No	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
transgene	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
heart	NULL
tissue	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
performed	NULL
on	NULL
RNA	NULL
derived	NULL
from	NULL
sorted	NULL
thymocyte	NULL
sub	NULL
populations	NULL
such	NULL
as	NULL
double	NULL
negative	NULL
(	NULL
DN	NULL
)	NULL
,	NULL
double	NULL
positive	NULL
(	NULL
DP	NULL
)	NULL
or	NULL
CD4*	NULL
and	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
a	NULL
CD8*	NULL
single	NULL
positive	NULL
thymocytes	NULL
(	NULL
CD8	NULL
*	NULL
SP	NULL
,	NULL
CD4+*	NULL
SP	NULL
)	NULL
from	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
showed	NULL
equal	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
all	NULL
thymocyte	NULL
sub	NULL
populations	NULL
(	NULL
Figure	NULL
1c	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
endogenous	NULL
Madl	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
DN	NULL
,	NULL
DP	NULL
and	NULL
to	NULL
a	NULL
weaker	NULL
extent	NULL
in	NULL
the	NULL
CD4*	NULL
SP	NULL
sub	NULL
population	NULL
(	NULL
Figure	NULL
1c	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
RT-PCR	NULL
analysis	NULL
on	NULL
sorted	NULL
thymocyte	NULL
sub	NULL
populations	NULL
from	NULL
wild-type	NULL
and	NULL
Mad1	NULL
transgenic	NULL
mice	NULL
showed	NULL
comparable	NULL
expression	NULL
of	NULL
other	NULL
Mad	NULL
family	NULL
members	NULL
such	NULL
as	NULL
Mxi	NULL
and	NULL
Mad4	NULL
in	NULL
different	NULL
thymocyte	NULL
sub	NULL
populations	NULL
(	NULL
Figure	NULL
1c	NULL
)	NULL
.	NULL

We	NULL
confirmed	NULL
immunokhistochemically	NULL
protein	NULL
expression	NULL
of	NULL
the	NULL
transgenic	NULL
Madl	NULL
protein	NULL
in	NULL
thymus	NULL
using	NULL
a	NULL
Madl	NULL
specific	NULL
antibody	NULL
.	NULL

Staining	NULL
for	NULL
the	NULL
endogenous	NULL
Madl	NULL
protein	NULL
was	NULL
detected	NULL
with	NULL
weak	NULL
intensity	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
staining	NULL
was	NULL
confirmed	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
Madl	NULL
specific	NULL
antibody	NULL
with	NULL
its	NULL
immunogenic	NULL
peptide	NULL
which	NULL
blocked	NULL
all	NULL
signal	NULL
(	NULL
Figure	NULL
1d	NULL
)	NULL
.	NULL

Lck-Mad1	NULL
transgenic	NULL
mice	NULL
exhibit	NULL
reduced	NULL
numbers	NULL
of	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
but	NULL
thymocyte	NULL
sub	NULL
populations	NULL
are	NULL
represented	NULL
normally	NULL
Mad1	NULL
expression	NULL
had	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
thymic	NULL
cellularity	NULL
:	NULL
thymus	NULL
size	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
total	NULL
thymocyte	NULL
number	NULL
,	NULL
was	NULL
reduced	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
relative	NULL
to	NULL
wild-type	NULL
control	NULL
littermates	NULL
(	NULL
Figure	NULL
2a	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
Madl	NULL
expression	NULL
on	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
thymocytes	NULL
from	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
and	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
4-10	NULL
weeks	NULL
old	NULL
)	NULL
were	NULL
analysed	NULL
by	NULL
three-color	NULL
flow	NULL
cytometry	NULL
using	NULL
antibodies	NULL
against	NULL
CD25	NULL
,	NULL
CD44	NULL
,	NULL
CD3s	NULL
,	NULL
CD69	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
CD4	NULL
and	NULL
CD8	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
different	NULL
thymocyte	NULL
sub	NULL
populations	NULL
.	NULL

These	NULL
analyses	NULL
indicated	NULL
that	NULL
Madl	NULL
expression	NULL
caused	NULL
no	NULL
significant	NULL
change	NULL
to	NULL
the	NULL
ratios	NULL
of	NULL
the	NULL
four	NULL
thymocyte	NULL
sub	NULL
populations	NULL
in	NULL
the	NULL
adult	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
more	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
four	NULL
DN	NULL
sub	NULL
populations	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
difference	NULL
between	NULL
control	NULL
littermates	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
indicating	NULL
no	NULL
developmental	NULL
blockade	NULL
in	NULL
early	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
/ck-Mad	NULL
!	NULL

l	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
level	NULL
of	NULL
all	NULL
cell	NULL
surface	NULL
markers	NULL
tested	NULL
was	NULL
unchanged	NULL
.	NULL

To	NULL
examine	NULL
any	NULL
effect	NULL
that	NULL
Madl	NULL
expression	NULL
might	NULL
have	NULL
on	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
,	NULL
lymph	NULL
node	NULL
cells	NULL
were	NULL
analysed	NULL
by	NULL
two-color	NULL
flow	NULL
cytometry	NULL
using	NULL
antibodies	NULL
against	NULL
CD4	NULL
and	NULL
CD8	NULL
to	NULL
discriminate	NULL
between	NULL
the	NULL
different	NULL
T	NULL
cell	NULL
sub	NULL
populations	NULL
.	NULL

These	NULL
analyses	NULL
showed	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
CD4*	NULL
and	NULL
CD8*+	NULL
SP	NULL
population	NULL
which	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
reduced	NULL
number	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
lymph	NULL
nodes	NULL
when	NULL
compared	NULL
with	NULL
control	NULL
littermates	NULL
(	NULL
Figure	NULL
2b	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Ick-Madl1	NULL
transgene	NULL
in	NULL
an	NULL
H-Y-TCR	NULL
background	NULL
perturbs	NULL
thymic	NULL
selection	NULL
One	NULL
way	NULL
that	NULL
Madl	NULL
might	NULL
reduce	NULL
thymic	NULL
cellularity	NULL
is	NULL
to	NULL
disrupt	NULL
positive	NULL
and/or	NULL
negative	NULL
selection	NULL
.	NULL

To	NULL
1165	NULL
Oncogene	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
1166	NULL
A.	NULL
BamH1/Not1	NULL
NotVBamHI1	NULL
Prommagslg	NULL
;	NULL
bpgomotor	NULL
Madt	NULL
hgh	NULL
(	NULL
2.1kb	NULL
)	NULL
GZIRA	NULL
--	NULL
--	NULL
-1	NULL
1000	NULL
B.	NULL
thymus	NULL
spleen	NULL
heart	NULL
co	NULL
Madl	NULL
co	NULL
Madi	NULL
co	NULL
Madl	NULL
C°	NULL
wi	NULL
mice	NULL
Mad1	NULL
tg	NULL
mice	NULL
&	NULL
44	NULL
FCS	NULL
&	NULL
4	NULL
5	NULL
5	NULL
Madi	NULL
a	NULL
-	NULL
a	NULL
-	NULL
@	NULL
a	NULL
a	NULL
a	NULL
4a	NULL
Msi	NULL
@	NULL
a	NULL
a	NULL
4	NULL
e	NULL
a	NULL
Mad4	NULL
‘	NULL
g	NULL
.	NULL

x	NULL
,	NULL
‘	NULL
.¢.¢	NULL
Bactin	NULL
D.	NULL
Figure	NULL
1	NULL
Generation	NULL
of	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
/ck-Mad1	NULL
transgenic	NULL
construct	NULL
.	NULL

A	NULL
1	NULL
kb	NULL
human	NULL
Mad	NULL
]	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
cloning	NULL
site	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
specific	NULL
proximal	NULL
ick	NULL
promoter	NULL
using	NULL
the	NULL
p1017	NULL
expression	NULL
vector	NULL
(	NULL
Chaffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Two	NULL
independent	NULL
transgenic	NULL
founder	NULL
lines	NULL
were	NULL
generated	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
showing	NULL
Mad1	NULL
expression	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
from	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
showing	NULL
the	NULL
expression	NULL
of	NULL
Madl	NULL
,	NULL
Mxi	NULL
and	NULL
Mad4	NULL
in	NULL
different	NULL
thymocyte	NULL
sub	NULL
populations	NULL
.	NULL

Radiolabelled	NULL
RT-PCR	NULL
reactions	NULL
were	NULL
separated	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
to	NULL
detect	NULL
the	NULL
expression	NULL
of	NULL
Mad1	NULL
,	NULL
Mxi	NULL
and	NULL
Mad4	NULL
in	NULL
different	NULL
thymocyte	NULL
sub	NULL
populations	NULL
of	NULL
wildtype	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
mice	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
tg	NULL
mice	NULL
)	NULL
.	NULL

Independent	NULL
RT-PCR	NULL
amplification	NULL
of	NULL
/-actin	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
efficient	NULL
cDNA	NULL
synthesis	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Immunohistochemical	NULL
staining	NULL
of	NULL
mouse	NULL
thymus	NULL
showing	NULL
Mad1	NULL
protein	NULL
expression	NULL
in	NULL
thymus	NULL
from	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
.	NULL

Frozen	NULL
sections	NULL
were	NULL
stained	NULL
for	NULL
Madl	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
immunogenic	NULL
peptide	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
examine	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
crossed	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
with	NULL
mice	NULL
expressing	NULL
a	NULL
transgenic	NULL
T	NULL
cell	NULL
receptor	NULL
specific	NULL
for	NULL
the	NULL
male	NULL
H-Y-antigen	NULL
presented	NULL
by	NULL
MHC	NULL
class	NULL
I	NULL
H-2D®	NULL
.	NULL

In	NULL
male	NULL
mice	NULL
,	NULL
the	NULL
well-established	NULL
model	NULL
system	NULL
for	NULL
negative	NULL
selection	NULL
,	NULL
almost	NULL
all	NULL
thymocytes	NULL
are	NULL
negatively	NULL
selected	NULL
during	NULL
Tcell	NULL
development	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
transgenic	NULL
H-Y-TCR	NULL
with	NULL
the	NULL
male	NULL
specific	NULL
H-Y	NULL
peptide	NULL
.	NULL

In	NULL
female	NULL
mice	NULL
,	NULL
where	NULL
no	NULL
male	NULL
H-Y-antigen	NULL
is	NULL
present	NULL
,	NULL
selection	NULL
of	NULL
MHC	NULL
class	NULL
TI-restricted	NULL
CD8*	NULL
SP	NULL
thymocytes	NULL
proceeds	NULL
very	NULL
efficiently	NULL
because	NULL
thymocytes	NULL
expressing	NULL
the	NULL
H-Y-specific	NULL
transgenic	NULL
TCR	NULL
are	NULL
positively	NULL
selected	NULL
(	NULL
Teh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
von	NULL
Boehmer	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

First	NULL
,	NULL
in	NULL
female	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
flow	NULL
cytometry	NULL
using	NULL
antibodies	NULL
against	NULL
CD4	NULL
and	NULL
CD8	NULL
and	NULL
the	NULL
transgenic	NULL
H-Y-TCR	NULL
(	NULL
T3.70	NULL
)	NULL
indicated	NULL
that	NULL
Madl	NULL
expression	NULL
had	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
positive	NULL
selection	NULL
.	NULL

Compared	NULL
with	NULL
female	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
female	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
Mad	NULL
!	NULL

transgene	NULL
exhibited	NULL
an	NULL
increased	NULL
proportion	NULL
of	NULL
DN	NULL
Oncogene	NULL
thymocytes	NULL
and	NULL
a	NULL
concomitant	NULL
reduction	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
DP	NULL
,	NULL
CD8*	NULL
SP	NULL
and	NULL
CD4*	NULL
SP	NULL
thymocytes	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
.	NULL

This	NULL
change	NULL
in	NULL
the	NULL
thymocyte	NULL
subset	NULL
distribution	NULL
was	NULL
also	NULL
obvious	NULL
in	NULL
the	NULL
absolute	NULL
cell	NULL
number	NULL
.	NULL

(	NULL
Figure	NULL
3a	NULL
table	NULL
)	NULL
.	NULL

Gating	NULL
on	NULL
the	NULL
CD8*	NULL
SP	NULL
population	NULL
showed	NULL
that	NULL
all	NULL
CD8*	NULL
SP	NULL
cells	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
transgenic	NULL
H-Y-TCR	NULL
indicating	NULL
that	NULL
these	NULL
cells	NULL
had	NULL
been	NULL
selected	NULL
by	NULL
interaction	NULL
of	NULL
the	NULL
TCR	NULL
«	NULL
/B	NULL
with	NULL
H-2D°	NULL
MHC	NULL
molecules	NULL
(	NULL
Figure	NULL
3b	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
reduced	NULL
percentage	NULL
of	NULL
DP	NULL
*	NULL
,	NULL
CD8*	NULL
SP	NULL
and	NULL
CD4*	NULL
SP	NULL
thymocytes	NULL
,	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
mature	NULL
CD8*	NULL
and	NULL
CD4*	NULL
population	NULL
in	NULL
the	NULL
periphery	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
3¢	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
transgenic	NULL
mice	NULL
,	NULL
female	NULL
/ck-Mad	NULL
!	NULL

x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
showed	NULL
a	NULL
decrease	NULL
in	NULL
thymic	NULL
cellularity	NULL
(	NULL
table	NULL
Figure	NULL
3a	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
thymic	NULL
cellularity	NULL
and	NULL
thymocyte	NULL
subset	NULL
distribution	NULL
analysis	NULL
both	NULL
demonstrate	NULL
that	NULL
Madl	NULL
reduces	NULL
the	NULL
efficiency	NULL
of	NULL
positive	NULL
selection	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
class	NULL
MHC-restricted	NULL
TCR	NULL
«	NULL
/	NULL
$	NULL
B	NULL
.	NULL

Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
A	NULL
&	NULL
wt	NULL
Madl	NULL
thymus	NULL
CD8	NULL
<	NULL
,	NULL
z	NULL
ym	NULL
d	NULL
``	NULL
ias	NULL
753	NULL
``	NULL
j	NULL
3.7	NULL
76.6	NULL
9.5	NULL
7.1	NULL
4	NULL
a	NULL
®	NULL
®	NULL
wt	NULL
Mad1	NULL
CD4	NULL
Mad1	NULL
lymph	NULL
nodes	NULL
``	NULL
1	NULL
15.4	NULL
B	NULL
.	NULL

<	NULL
]	NULL
3	NULL
Ll	NULL
5	NULL
4	NULL
ND	NULL
E	NULL
=	NULL
E	NULL
ic	NULL
_	NULL
E	NULL
E	NULL
42.6	NULL
6	NULL
:	NULL
35.3	NULL
g	NULL
a	NULL
``	NULL
..	NULL
7	NULL
3	NULL
a	NULL
10	NULL
10	NULL
10	NULL
1	NULL
10°	NULL
10	NULL
10	NULL
w	NULL
Mad1	NULL
»	NULL
CD4	NULL
Figure	NULL
2	NULL
Lck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
exhibit	NULL
reduced	NULL
numbers	NULL
of	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
but	NULL
show	NULL
normal	NULL
thymocyte	NULL
sub	NULL
populations	NULL
.	NULL

(	NULL
a	NULL
left	NULL
panel	NULL
)	NULL
Representative	NULL
flow	NULL
cytometry	NULL
profiles	NULL
of	NULL
thymocytes	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
stained	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

Numbers	NULL
in	NULL
each	NULL
quadrant	NULL
indicate	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
population	NULL
.	NULL

(	NULL
a	NULL
right	NULL
panel	NULL
)	NULL
Total	NULL
thymocyte	NULL
cell	NULL
numbers	NULL
from	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
.	NULL

Thymus	NULL
tissue	NULL
was	NULL
isolated	NULL
from	NULL
mice	NULL
between	NULL
4	NULL
and	NULL
12	NULL
weeks	NULL
old	NULL
and	NULL
the	NULL
total	NULL
cell	NULL
number	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
haemacytometer	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
a	NULL
mean	NULL
of	NULL
20	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
left	NULL
panel	NULL
)	NULL
Representative	NULL
flow	NULL
cytometric	NULL
profiles	NULL
of	NULL
lymph	NULL
node	NULL
cells	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
stained	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
cell	NULL
surface	NULL
markers	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

Numbers	NULL
in	NULL
each	NULL
quadrant	NULL
indicate	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
population	NULL
.	NULL

(	NULL
b	NULL
right	NULL
panel	NULL
)	NULL
Total	NULL
cell	NULL
numbers	NULL
in	NULL
lymph	NULL
nodes	NULL
from	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
.	NULL

Lymph	NULL
nodes	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Madl	NULL
)	NULL
were	NULL
isolated	NULL
and	NULL
the	NULL
total	NULL
cell	NULL
number	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
haemacytometer	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
a	NULL
mean	NULL
of	NULL
10	NULL
independent	NULL
experiments	NULL
A	NULL
.	NULL

B	NULL
.	NULL

C	NULL
6	NULL
female	NULL
H-Y-TCR	NULL
(	NULL
brk	NULL
)	NULL
cell	NULL
number	NULL
x10	NULL
femule	NULL
H-Y~TCR	NULL
(	NULL
b/s	NULL
)	NULL
female	NULL
He¥	NULL
<	NULL
TCR	NULL
(	NULL
k	NULL
)	NULL
cbs	NULL
total	NULL
-	NULL
127.0	NULL
&	NULL
73	NULL
%	NULL
=	NULL
173	NULL
x	NULL
10	NULL
cons	NULL
a	NULL
2794	NULL
&	NULL
5	NULL
3	NULL
DN	NULL
123	NULL
2	NULL
3	NULL
$	NULL
DP	NULL
697	NULL
``	NULL
L	NULL
CDS*	NULL
222	NULL
s	NULL
cD4r	NULL
_	NULL
224	NULL
co	NULL
``	NULL
40	NULL
``	NULL
ao	NULL
!	NULL

act	NULL
aot	NULL
qo	NULL
``	NULL
female	NULL
Madl	NULL
x	NULL
H-Y-TCR	NULL
(	NULL
bi	NULL
)	NULL
female	NULL
Mad	NULL
]	NULL
x	NULL
H-Y-TCR	NULL
(	NULL
b/g	NULL
)	NULL
=	NULL
total	NULL
.	NULL

61.0	NULL
771	NULL
%	NULL
=77	NULL
x	NULL
106	NULL
=	NULL
i	NULL
86	NULL
i	NULL
px	NULL
__	NULL
224	NULL
B	NULL
DP	NULL
246	NULL
``	NULL
C	NULL
©bg+	NULL
-	NULL
10.1	NULL
e	NULL
coat	NULL
.	NULL

38	NULL
&	NULL
&	NULL
anti	NULL
H-¥-TCR	NULL
CD4	NULL
Figure	NULL
3	NULL
Expression	NULL
of	NULL
the	NULL
/ck-Mad	NULL
!	NULL

transgene	NULL
in	NULL
an	NULL
H-Y-TCR	NULL
background	NULL
perturbs	NULL
thymic	NULL
selection	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Thymocytes	NULL
from	NULL
female	NULL
control	NULL
littermates	NULL
(	NULL
female	NULL
H-Y-TCR	NULL
)	NULL
and	NULL
female	NULL
/ck-Mad	NULL
!	NULL

x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
female	NULL
Mad1	NULL
x	NULL
H-Y-TCR	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
CD4	NULL
and	NULL
CD8	NULL
followed	NULL
by	NULL
two-color	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Numbers	NULL
in	NULL
each	NULL
quadrant	NULL
indicate	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
sub	NULL
population	NULL
.	NULL

The	NULL
table	NULL
shows	NULL
the	NULL
absolute	NULL
cell	NULL
number	NULL
in	NULL
each	NULL
sub	NULL
population	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Histograms	NULL
of	NULL
CD8	NULL
*	NULL
SP	NULL
thymocytes	NULL
from	NULL
female	NULL
control	NULL
littermates	NULL
(	NULL
female	NULL
H-Y-TCR	NULL
)	NULL
and	NULL
female	NULL
/ck-Mad	NULL
!	NULL

x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
female	NULL
Mad1	NULL
x	NULL
H-Y-TCR	NULL
)	NULL
.	NULL

Percentage	NULL
and	NULL
absolute	NULL
cell	NULL
number	NULL
of	NULL
H-Y-TCR	NULL
positive	NULL
thymocytes	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
Lymph	NULL
node	NULL
cells	NULL
from	NULL
female	NULL
control	NULL
littermates	NULL
(	NULL
female	NULL
H-Y-TCR	NULL
)	NULL
and	NULL
female	NULL
/ck-Madl	NULL
x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
female	NULL
Mad1	NULL
x	NULL
H-Y-TCR	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
CD4	NULL
and	NULL
CD8	NULL
followed	NULL
by	NULL
two-color	NULL
flow	NULL
cytometry	NULL
analysis	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
sub	NULL
population	NULL
is	NULL
indicated	NULL
1167	NULL
Oncogene	NULL
a	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
1168	NULL
Second	NULL
,	NULL
thymuses	NULL
from	NULL
male	NULL
H-2D	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
are	NULL
in	NULL
general	NULL
hypocellular	NULL
due	NULL
to	NULL
extensive	NULL
negative	NULL
selection	NULL
,	NULL
exhibiting	NULL
a	NULL
particularly	NULL
marked	NULL
reduction	NULL
of	NULL
cortical	NULL
CD3+	NULL
CD4+*	NULL
CD8	NULL
#	NULL
+*+DP	NULL
cells	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
thymuses	NULL
from	NULL
male	NULL
/ck-Mad1	NULL
x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
with	NULL
control	NULL
H-Y-TCR	NULL
transgenic	NULL
mice	NULL
showed	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
thymic	NULL
cellularity	NULL
:	NULL
both	NULL
were	NULL
extremely	NULL
hypocellular	NULL
.	NULL

Examination	NULL
of	NULL
negative	NULL
selection	NULL
using	NULL
flow	NULL
cytometry	NULL
revealed	NULL
differences	NULL
between	NULL
H-Y-TCR	NULL
transgenic	NULL
and	NULL
/ck-Mad1	NULL
x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
mice	NULL
.	NULL

Antibodies	NULL
against	NULL
CD4	NULL
and	NULL
CD8	NULL
showed	NULL
that	NULL
expression	NULL
of	NULL
Madl	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
DN	NULL
thymocytes	NULL
accompanied	NULL
by	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
proportions	NULL
of	NULL
DP+	NULL
,	NULL
CD4*	NULL
and	NULL
CD8+	NULL
SP	NULL
thymocytes	NULL
.	NULL

Staining	NULL
of	NULL
lymph	NULL
node	NULL
cells	NULL
with	NULL
the	NULL
same	NULL
antibodies	NULL
however	NULL
showed	NULL
only	NULL
a	NULL
minor	NULL
reduction	NULL
in	NULL
the	NULL
representation	NULL
of	NULL
mature	NULL
CD8	NULL
*	NULL
cells	NULL
in	NULL
the	NULL
periphery	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
summarize	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
a	NULL
significant	NULL
difference	NULL
in	NULL
total	NULL
thymocyte	NULL
number	NULL
between	NULL
male	NULL
/ck-Madl	NULL
x	NULL
H-Y-TCR	NULL
double	NULL
transgenic	NULL
and	NULL
male	NULL
H-Y-TCR	NULL
mice	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
effect	NULL
on	NULL
the	NULL
percentage	NULL
of	NULL
CD8*	NULL
cells	NULL
in	NULL
the	NULL
periphery	NULL
was	NULL
extremely	NULL
mild	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
only	NULL
thing	NULL
we	NULL
do	NULL
conclude	NULL
from	NULL
these	NULL
data	NULL
is	NULL
that	NULL
Mad1	NULL
expression	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
reduce	NULL
negative	NULL
selection	NULL
.	NULL

Impaired	NULL
mitogen-induced	NULL
proliferation	NULL
in	NULL
lck-Madl1	NULL
transgenic	NULL
mice	NULL
In	NULL
the	NULL
absence	NULL
of	NULL
activation	NULL
,	NULL
T	NULL
cells	NULL
are	NULL
arrested	NULL
in	NULL
GO	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
the	NULL
TCR	NULL
triggers	NULL
progression	NULL
into	NULL
S	NULL
phase	NULL
and	NULL
consequently	NULL
proliferation	NULL
.	NULL

C-myc	NULL
is	NULL
well	NULL
characterized	NULL
as	NULL
a	NULL
gene	NULL
that	NULL
is	NULL
rapidly	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
following	NULL
mitogenic	NULL
stimulation	NULL
(	NULL
Carding	NULL
and	NULL
Reem	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
c-mye	NULL
appears	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
thymocyte	NULL
proliferation	NULL
since	NULL
antisense	NULL
oligonucleo-tide	NULL
inhibition	NULL
of	NULL
c-Myc	NULL
expression	NULL
blocks	NULL
S	NULL
phase	NULL
entry	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
Heikkila	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
and	NULL
because	NULL
of	NULL
the	NULL
dramatic	NULL
effect	NULL
of	NULL
Madl	NULL
expression	NULL
on	NULL
the	NULL
total	NULL
thymocyte	NULL
cell	NULL
number	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
Madl	NULL
expression	NULL
on	NULL
mitogen-induced	NULL
proliferation	NULL
.	NULL

Thymocytes	NULL
and	NULL
purified	NULL
T	NULL
cells	NULL
from	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
or	NULL
control	NULL
littermates	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
antiCD3/CD28	NULL
antibody	NULL
or	NULL
phorbol	NULL
myr-istate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
Ionomycin	NULL
,	NULL
and	NULL
proliferation	NULL
assayed	NULL
by	NULL
[	NULL
PH	NULL
]	NULL
-thymidine	NULL
incorporation	NULL
.	NULL

Madl	NULL
expression	NULL
significantly	NULL
suppressed	NULL
proliferation	NULL
of	NULL
both	NULL
thymocytes	NULL
and	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
either	NULL
mitogenic	NULL
stimulus	NULL
(	NULL
Figure	NULL
4a	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
level	NULL
of	NULL
TCR	NULL
,	NULL
CD3s	NULL
expression	NULL
or	NULL
CD28	NULL
expression	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
which	NULL
was	NULL
unaffected	NULL
by	NULL
Mad1	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suppression	NULL
was	NULL
not	NULL
reversed	NULL
by	NULL
addition	NULL
of	NULL
exogenous	NULL
recombinant	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
indicating	NULL
that	NULL
the	NULL
impaired	NULL
proliferation	NULL
is	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
impaired	NULL
autocrine	NULL
IL-2	NULL
stimulation	NULL
(	NULL
Figure	NULL
4a	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

p53	NULL
is	NULL
implicated	NULL
in	NULL
suppression	NULL
of	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
DNA	NULL
Oncogene	NULL
damage	NULL
,	NULL
oncogene	NULL
deregulation	NULL
(	NULL
for	NULL
review	NULL
Schwartz	NULL
and	NULL
Rotter	NULL
,	NULL
1998	NULL
)	NULL
and	NULL
inhibition	NULL
of	NULL
CD95/Fas	NULL
signalling	NULL
(	NULL
Zoernig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
to	NULL
determine	NULL
whether	NULL
Madl1-induced	NULL
growth	NULL
arrest	NULL
is	NULL
dependent	NULL
upon	NULL
expression	NULL
of	NULL
p53	NULL
.	NULL

Leck-Mad1	NULL
transgenic	NULL
mice	NULL
were	NULL
crossed	NULL
with	NULL
p53w_-	NULL
mice	NULL
(	NULL
Donehower	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Thymocytes	NULL
from	NULL
p53	NULL
and	NULL
p53~-	NULL
non-transgenic	NULL
and	NULL
Ick-Madl	NULL
transgenic	NULL
mice	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
their	NULL
proliferative	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
mitogenic	NULL
stimulation	NULL
.	NULL

Absence	NULL
of	NULL
p53	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
Madl	NULL
to	NULL
suppress	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
.	NULL

Mad1-suppression	NULL
of	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
is	NULL
not	NULL
accompanied	NULL
by	NULL
alterations	NULL
in	NULL
described	NULL
G1	NULL
phase	NULL
cell	NULL
cycle	NULL
regulators	NULL
Although	NULL
the	NULL
Myc/Max/Mad1	NULL
network	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
Eilers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Evan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Keath	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Heikkila	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Roussel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
its	NULL
precise	NULL
relationship	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
machinery	NULL
remains	NULL
largely	NULL
obscure	NULL
.	NULL

Progression	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
controlled	NULL
by	NULL
different	NULL
active	NULL
cyclin/edk	NULL
complexes	NULL
whose	NULL
activities	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
availability	NULL
of	NULL
regulatory	NULL
cyclin	NULL
subunits	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
major	NULL
cdk-inhibitory	NULL
proteins	NULL
and	NULL
by	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
the	NULL
cyclin/edk	NULL
complexes	NULL
(	NULL
Albrecht	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
and	NULL
ref	NULL
.	NULL

therein	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
Madl	NULL
expression	NULL
has	NULL
any	NULL
effect	NULL
on	NULL
expression	NULL
or	NULL
activation	NULL
of	NULL
these	NULL
regulators	NULL
.	NULL

In	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
stimulation	NULL
,	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
constitutively	NULL
expressed	NULL
cyclin-dependent	NULL
kinases	NULL
cdk2	NULL
and	NULL
cdk4	NULL
remain	NULL
unchanged	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cyclin	NULL
E	NULL
and	NULL
cyclin	NULL
D2	NULL
are	NULL
up	NULL
regulated	NULL
.	NULL

Cdk	NULL
inhibitor	NULL
p27	NULL
is	NULL
present	NULL
in	NULL
quiescent	NULL
thymocytes	NULL
but	NULL
rapidly	NULL
degraded	NULL
following	NULL
mitogen	NULL
stimulation	NULL
(	NULL
Boonen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
whereas	NULL
the	NULL
Cdk	NULL
inhibitor	NULL
p21	NULL
is	NULL
undetectable	NULL
in	NULL
quiescent	NULL
T	NULL
cells	NULL
but	NULL
induced	NULL
by	NULL
antiCD3/CD28	NULL
activation	NULL
(	NULL
Linette	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5a	NULL
,	NULL
despite	NULL
the	NULL
profound	NULL
growth-inhibitory	NULL
effect	NULL
of	NULL
Madl	NULL
on	NULL
thymocytes	NULL
,	NULL
the	NULL
expression	NULL
patterns	NULL
of	NULL
all	NULL
of	NULL
these	NULL
G1	NULL
phase	NULL
cell	NULL
cycle	NULL
regulators	NULL
was	NULL
unaffected	NULL
(	NULL
Figure	NULL
Sa	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
immediate	NULL
early	NULL
kinetics	NULL
and	NULL
extent	NULL
of	NULL
expression	NULL
of	NULL
c-myc	NULL
was	NULL
unaffected	NULL
by	NULL
growth-inhibitory	NULL
levels	NULL
of	NULL
Madl	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
cyclin	NULL
A	NULL
,	NULL
an	NULL
indicator	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
S	NULL
phase	NULL
entry	NULL
,	NULL
was	NULL
markedly	NULL
suppressed	NULL
in	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
thymocytes	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
stimulation	NULL
.	NULL

Expression	NULL
of	NULL
cyclin	NULL
A	NULL
in	NULL
unstimulated	NULL
cells	NULL
was	NULL
comparable	NULL
in	NULL
wild-type	NULL
and	NULL
transgenic	NULL
thymocytes	NULL
(	NULL
Figure	NULL
5a	NULL
)	NULL
.	NULL

In	NULL
fibroblasts	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
an	NULL
increased	NULL
level	NULL
of	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
precedes	NULL
entry	NULL
into	NULL
S	NULL
phase	NULL
induced	NULL
by	NULL
c-Myc	NULL
activation	NULL
(	NULL
Steiner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
that	NULL
this	NULL
is	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
cyclin	NULL
A	NULL
by	NULL
Myc	NULL
(	NULL
Rudolph	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
were	NULL
curious	NULL
to	NULL
see	NULL
if	NULL
Madl	NULL
expression	NULL
in	NULL
thymocytes	NULL
would	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
a	NULL
A	NULL
.	NULL

3	NULL
CD3/CD28	NULL
CD3/CD28	NULL
4+	NULL
IL-2	NULL
PMA/Iono	NULL
+	NULL
IL-2	NULL
8	NULL
0	NULL
/	NULL
'	NULL
60	NULL
100	NULL
a	NULL
m	NULL
/	NULL
50	NULL
7	NULL
|	NULL
=	NULL
30	NULL
-	NULL
30	NULL
4	NULL
80	NULL
5	NULL
;	NULL
/	NULL
ao	NULL
-	NULL
a	NULL
E	NULL
8	NULL
‘	NULL
20	NULL
7	NULL
20	NULL
-	NULL
30	NULL
-	NULL
/	NULL
£	NULL
|	NULL
40	NULL
{	NULL
g	NULL
10	NULL
-	NULL
10	NULL
-	NULL
l	NULL
20	NULL
4	NULL
2	NULL
DJ/D/	NULL
10	NULL
{	NULL
@	NULL
20	NULL
fo	NULL
0	NULL
M	NULL
a	NULL
|	NULL
--	NULL
B-7-	NULL
z-	NULL
--	NULL
-	NULL
o	NULL
P/Dr/ID	NULL
oo	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
1	NULL
a	NULL
a	NULL
,	NULL
t	NULL
2-	NULL
u	NULL
3.	NULL
time	NULL
in	NULL
days	NULL
-a-	NULL
wt	NULL
-O-	NULL
Madl	NULL
B	NULL
.	NULL

B	NULL
CD3/CD28	NULL
CD3/CD28	NULL
\a	NULL
|	NULL
so	NULL
[	NULL
=	NULL
60	NULL
2:2	NULL
;	NULL
50	NULL
{	NULL
f	NULL
40	NULL
4	NULL
A	NULL
é	NULL
``	NULL
g	NULL
40	NULL
~	NULL
/	NULL
30	NULL
§	NULL
&	NULL
/	NULL
.	NULL

-a-	NULL
pS3	NULL
+/-3	NULL
-	NULL
/	NULL
20	NULL
|	NULL
-O-	NULL
p53	NULL
+/-	NULL
Mad1	NULL
g	NULL
j	NULL
:	NULL
./	NULL
‘	NULL
D//	NULL
©	NULL
‘	NULL
l	NULL
la	NULL
.	NULL

Fizz-M	NULL
di	NULL
A	NULL
t	NULL
g	NULL
fe	NULL
T	NULL
enn	NULL
``	NULL
s	NULL
28	NULL
«	NULL
00000000	NULL
f	NULL
P	NULL
sees	NULL
,	NULL
a	NULL
a	NULL
;	NULL
o	NULL
‘	NULL
D/	NULL
,	NULL
,	NULL
,	NULL
o	NULL
Eg_	NULL
,	NULL
P	NULL
&	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
time	NULL
in	NULL
days	NULL
Figure	NULL
4	NULL
Impaired	NULL
mitogen-induced	NULL
proliferation	NULL
in	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
is	NULL
p53-independent	NULL
.	NULL

(	NULL
«	NULL
)	NULL
Thymocytes	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
were	NULL
plated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
and	NULL
treated	NULL
with	NULL
either	NULL
antiCD3/CD28	NULL
antibody	NULL
(	NULL
CD3/CD28	NULL
)	NULL
or	NULL
PMA/Ionomycin	NULL
(	NULL
PMA/Iono	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Mean	NULL
incorporation	NULL
of	NULL
was	NULL
assessed	NULL
from	NULL
triplicate	NULL
wells	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
treatment	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Thymocytes	NULL
from	NULL
hetero-	NULL
and	NULL
homozygous	NULL
p53	NULL
mutant	NULL
mice	NULL
,	NULL
either	NULL
with	NULL
or	NULL
without	NULL
the	NULL
transgene	NULL
,	NULL
were	NULL
plated	NULL
on	NULL
anti-CD3/CD28	NULL
coated	NULL
plates	NULL
(	NULL
CD3/CD28	NULL
)	NULL
.	NULL

Incorporation	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
-thymidine	NULL
was	NULL
assessed	NULL
from	NULL
triplicate	NULL
wells	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
treatment	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
anti-CD3/CD28	NULL
treatment	NULL
.	NULL

Thymocytes	NULL
from	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
and	NULL
control	NULL
littermates	NULL
were	NULL
stimulated	NULL
for	NULL
48	NULL
h	NULL
with	NULL
antiCD3/CD28	NULL
,	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
cells	NULL
and	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
performed	NULL
using	NULL
an	NULL
anti-cyclin	NULL
E	NULL
antibody	NULL
or	NULL
control	NULL
antibody	NULL
with	NULL
histone	NULL
H1	NULL
as	NULL
a	NULL
substrate	NULL
(	NULL
Figure	NULL
5b	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
no	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
was	NULL
detectable	NULL
in	NULL
non-stimulated	NULL
thymocytes	NULL
.	NULL

However	NULL
,	NULL
following	NULL
co-stimulation	NULL
with	NULL
antiCD3/CD28	NULL
,	NULL
we	NULL
observed	NULL
clear	NULL
increases	NULL
in	NULL
cyclin	NULL
E	NULL
kinase	NULL
activity	NULL
in	NULL
both	NULL
wild-type	NULL
and	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
thymocytes	NULL
exhibit	NULL
reduced	NULL
cyclin	NULL
A	NULL
levels	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
co-stimulation	NULL
,	NULL
this	NULL
was	NULL
not	NULL
accompanied	NULL
by	NULL
any	NULL
detectable	NULL
suppression	NULL
of	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
Madl	NULL
in	NULL
T	NULL
cells	NULL
blocks	NULL
only	NULL
the	NULL
first	NULL
GO-S	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
but	NULL
not	NULL
subsequent	NULL
cell	NULL
cycles	NULL
Initial	NULL
entry	NULL
of	NULL
quiescent	NULL
T	NULL
cells	NULL
from	NULL
G0	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
mechanistically	NULL
discrete	NULL
process	NULL
from	NULL
the	NULL
M-G1	NULL
transition	NULL
of	NULL
continuously	NULL
proliferating	NULL
cells	NULL
.	NULL

Unlike	NULL
exit	NULL
from	NULL
M	NULL
phase	NULL
,	NULL
exit	NULL
from	NULL
G0	NULL
is	NULL
accompanied	NULL
by	NULL
transient	NULL
expression	NULL
of	NULL
immediate	NULL
early	NULL
genes	NULL
and	NULL
the	NULL
GO-S	NULL
transition	NULL
takes	NULL
far	NULL
longer	NULL
than	NULL
the	NULL
equivalent	NULL
transition	NULL
from	NULL
M	NULL
to	NULL
S	NULL
phase	NULL
.	NULL

It	NULL
is	NULL
still	NULL
unclear	NULL
whether	NULL
the	NULL
Myc/Max/Madl1	NULL
network	NULL
is	NULL
primarily	NULL
concerned	NULL
with	NULL
the	NULL
GO-G1	NULL
transition	NULL
or	NULL
whether	NULL
it	NULL
fulfils	NULL
a	NULL
reoccurring	NULL
or	NULL
sustained	NULL
role	NULL
in	NULL
continuously	NULL
proliferating	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
growth-inhibitory	NULL
effect	NULL
of	NULL
Madl	NULL
was	NULL
exerted	NULL
only	NULL
at	NULL
the	NULL
exit	NULL
from	NULL
quiescence	NULL
or	NULL
also	NULL
in	NULL
each	NULL
reoccurring	NULL
cell	NULL
cycle	NULL
.	NULL

To	NULL
monitor	NULL
proliferation	NULL
over	NULL
time	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
stimulation	NULL
purified	NULL
T	NULL
cells	NULL
from	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
or	NULL
control	NULL
littermates	NULL
were	NULL
labelled	NULL
in	NULL
vitro	NULL
for	NULL
72	NULL
h	NULL
using	NULL
the	NULL
fluorescent	NULL
dye	NULL
CFSE	NULL
(	NULL
Wells	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
dye	NULL
binds	NULL
irreversibly	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
and	NULL
segregates	NULL
equally	NULL
between	NULL
daughter	NULL
cells	NULL
upon	NULL
cell	NULL
division	NULL
.	NULL

As	NULL
cells	NULL
divide	NULL
their	NULL
fluorescence	NULL
halves	NULL
sequentially	NULL
with	NULL
each	NULL
generation	NULL
.	NULL

When	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
gating	NULL
on	NULL
the	NULL
living	NULL
cells	NULL
showed	NULL
that	NULL
unstimulated	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
either	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
or	NULL
control	NULL
littermates	NULL
exhibited	NULL
a	NULL
sharp	NULL
single	NULL
peak	NULL
indicative	NULL
of	NULL
no	NULL
cell	NULL
1169	NULL
Oncogene	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
1170	NULL
A	NULL
.	NULL

B.	NULL
vt	NULL
Mad1	NULL
wt	NULL
Madt	NULL
cbaicbrs	NULL
ns	NULL
ans	NULL
IP	NULL
:	NULL
i	NULL
«	NULL
ous	NULL
o	NULL
--	NULL
-	NULL
que	NULL
cyclin	NULL
E	NULL
edk2	NULL
com	NULL
>	NULL
<	NULL
em	NULL
>	NULL
Gg	NULL
nar	NULL
ee	NULL
pat	NULL
cyclin	NULL
D2*	NULL
cyclin	NULL
D3	NULL
cdkd	NULL
coun	NULL
-	NULL
<	NULL
e	NULL
«	NULL
lie	NULL
comm	NULL
cyclin	NULL
A	NULL
<	NULL
p	NULL
lb	NULL
coms	NULL
.-	NULL
.	NULL

wt	NULL
Mad1	NULL
wt	NULL
cyeE	NULL
co	NULL
cyeR	NULL
-	NULL
co	NULL
cye	NULL
E.	NULL
co	NULL
cyeR	NULL
-	NULL
co	NULL
NS	NULL
Figure	NULL
5	NULL
No	NULL
alteration	NULL
in	NULL
key	NULL
cell	NULL
cycle	NULL
regulators	NULL
during	NULL
Mad1-suppression	NULL
of	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Thymocytes	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
were	NULL
either	NULL
harvested	NULL
immediately	NULL
(	NULL
NS	NULL
)	NULL
or	NULL
plated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
immobilized	NULL
anti-CD3/CD28	NULL
antibody	NULL
for	NULL
48	NULL
h	NULL
(	NULL
CD3/CD28	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
important	NULL
G1	NULL
phase	NULL
cell	NULL
cycle	NULL
regulators	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
activation	NULL
was	NULL
then	NULL
analysed	NULL
by	NULL
Western	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Where	NULL
indicated	NULL
with	NULL
an	NULL
asterisk	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
antiCD3/CD28	NULL
antibody	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Extracts	NULL
of	NULL
thymocytes	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
,	NULL
either	NULL
before	NULL
(	NULL
NS	NULL
)	NULL
or	NULL
after	NULL
treatment	NULL
with	NULL
immobilized	NULL
anti-CD3/CD28	NULL
(	NULL
CD3/CD28	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
Cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
in	NULL
wild-type	NULL
and	NULL
in	NULL
Mad	NULL
]	NULL
transgenic	NULL
thymocytes	NULL
was	NULL
assessed	NULL
by	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
using	NULL
either	NULL
an	NULL
anti-cyclin	NULL
E	NULL
serum	NULL
(	NULL
cye	NULL
E	NULL
)	NULL
or	NULL
a	NULL
control	NULL
antibody	NULL
(	NULL
co	NULL
)	NULL
with	NULL
histone	NULL
H1	NULL
as	NULL
a	NULL
substrate	NULL
division	NULL
(	NULL
Figure	NULL
6a	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
littermates	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
several	NULL
distinct	NULL
peaks	NULL
representing	NULL
successive	NULL
cell	NULL
divisions	NULL
.	NULL

We	NULL
observed	NULL
marked	NULL
heterogeneity	NULL
and	NULL
asynchrony	NULL
in	NULL
the	NULL
kinetics	NULL
of	NULL
cell	NULL
division	NULL
,	NULL
with	NULL
some	NULL
cells	NULL
having	NULL
divided	NULL
as	NULL
many	NULL
as	NULL
five	NULL
times	NULL
after	NULL
72	NULL
h	NULL
of	NULL
co-stimulation	NULL
(	NULL
peak	NULL
6	NULL
)	NULL
whilst	NULL
others	NULL
remained	NULL
undivided	NULL
(	NULL
peak	NULL
1	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
consistently	NULL
exhibited	NULL
fewer	NULL
cell	NULL
divisions	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
treatment	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
reduced	NULL
peak	NULL
sizes	NULL
and	NULL
a	NULL
smaller	NULL
percentages	NULL
of	NULL
divided	NULL
cells	NULL
.	NULL

19.0	NULL
%	NULL
of	NULL
the	NULL
alive	NULL
T	NULL
cells	NULL
remained	NULL
undivided	NULL
in	NULL
the	NULL
control	NULL
T	NULL
cell	NULL
population	NULL
,	NULL
whereas	NULL
36.9	NULL
%	NULL
of	NULL
the	NULL
alive	NULL
T	NULL
cells	NULL
of	NULL
Ick-Madl	NULL
transgenic	NULL
T	NULL
cells	NULL
remained	NULL
undivided	NULL
(	NULL
Figure	NULL
6a	NULL
,	NULL
left	NULL
panel	NULL
and	NULL
table	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
initial	NULL
GO-G1	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
clearly	NULL
inhibited	NULL
by	NULL
Madl	NULL
transgene	NULL
expression	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
Madl	NULL
expression	NULL
on	NULL
cells	NULL
already	NULL
in	NULL
cycle	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
already	NULL
divided	NULL
three	NULL
times	NULL
(	NULL
peak	NULL
4	NULL
)	NULL
were	NULL
sorted	NULL
and	NULL
re-plated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
on	NULL
anti-CD3/CD28	NULL
coated	NULL
plates	NULL
.	NULL

The	NULL
CFSE	NULL
profiles	NULL
from	NULL
both	NULL
transgenic	NULL
mice	NULL
and	NULL
control	NULL
littermates	NULL
were	NULL
then	NULL
compared	NULL
.	NULL

We	NULL
observed	NULL
negligible	NULL
differences	NULL
between	NULL
CFSE	NULL
profiles	NULL
of	NULL
control	NULL
and	NULL
thymocytes	NULL
(	NULL
Figure	NULL
6b	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Madl	NULL
exerts	NULL
no	NULL
antiproliferative	NULL
influence	NULL
over	NULL
cells	NULL
already	NULL
past	NULL
the	NULL
GO0-G1	NULL
boundary	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
confirmed	NULL
by	NULL
CFSE	NULL
staining	NULL
combined	NULL
with	NULL
Hoechst	NULL
33343	NULL
staining	NULL
.	NULL

Anti-CD3/CD28	NULL
activated	NULL
,	NULL
CFSE-stained	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
intercalating	NULL
dye	NULL
Hoechst	NULL
33343	NULL
and	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Both	NULL
CFSE-and	NULL
cell	NULL
cycle	NULL
profiles	NULL
were	NULL
obtained	NULL
.	NULL

By	NULL
gating	NULL
on	NULL
different	NULL
peaks	NULL
in	NULL
the	NULL
CFSE	NULL
profile	NULL
,	NULL
the	NULL
corresponding	NULL
Hoechst	NULL
cell	NULL
cycle	NULL
profiles	NULL
were	NULL
then	NULL
identified	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
distribution	NULL
of	NULL
the	NULL
nondivided	NULL
population	NULL
of	NULL
Oncogene	NULL
CFSE	NULL
stained	NULL
T	NULL
cells	NULL
(	NULL
peak	NULL
1	NULL
)	NULL
revealed	NULL
a	NULL
slightly	NULL
increased	NULL
number	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
G1	NULL
and	NULL
a	NULL
reduced	NULL
number	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
in	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
compared	NULL
to	NULL
wild-type	NULL
littermates	NULL
.	NULL

Analysing	NULL
the	NULL
cell	NULL
cycle	NULL
distribution	NULL
of	NULL
cycling	NULL
cells	NULL
by	NULL
gating	NULL
on	NULL
a	NULL
population	NULL
of	NULL
already	NULL
divided	NULL
T	NULL
cells	NULL
(	NULL
peak	NULL
2	NULL
)	NULL
showed	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
profile	NULL
between	NULL
wild-type	NULL
and	NULL
/ck-	NULL
Madl	NULL
transgenic	NULL
mice	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
Mad1	NULL
inhibits	NULL
only	NULL
the	NULL
entry	NULL
in	NULL
the	NULL
first	NULL
cycle	NULL
and	NULL
does	NULL
not	NULL
affect	NULL
normal	NULL
cell	NULL
cycle	NULL
progression	NULL
of	NULL
already	NULL
cycling	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
6¢	NULL
)	NULL
.	NULL

c-Myc	NULL
can	NULL
overcome	NULL
the	NULL
proliferation	NULL
block	NULL
caused	NULL
by	NULL
Mad1	NULL
expression	NULL
The	NULL
general	NULL
model	NULL
of	NULL
the	NULL
Myc/Max/Mad1	NULL
network	NULL
holds	NULL
that	NULL
proteins	NULL
of	NULL
the	NULL
Mad	NULL
family	NULL
compete	NULL
with	NULL
Myc	NULL
for	NULL
Max	NULL
and	NULL
that	NULL
Mad/Max	NULL
heterodimers	NULL
compete	NULL
with	NULL
Myc/Max	NULL
heterodimers	NULL
for	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
relative	NULL
affinities	NULL
of	NULL
Myc	NULL
and	NULL
Mad	NULL
proteins	NULL
for	NULL
Max	NULL
and	NULL
DNA	NULL
,	NULL
nor	NULL
the	NULL
precise	NULL
stoichio-metries	NULL
of	NULL
Myc	NULL
and	NULL
Mad	NULL
proteins	NULL
in	NULL
normal	NULL
cells	NULL
have	NULL
been	NULL
well	NULL
defined	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
normal	NULL
cells	NULL
express	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
c-Myc	NULL
protein	NULL
and	NULL
that	NULL
levels	NULL
of	NULL
c-Myc	NULL
in	NULL
tumor	NULL
cells	NULL
can	NULL
be	NULL
up	NULL
to	NULL
100	NULL
times	NULL
higher	NULL
(	NULL
Moore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

To	NULL
test	NULL
in	NULL
vivo	NULL
the	NULL
notion	NULL
that	NULL
Myc	NULL
and	NULL
Madl	NULL
compete	NULL
functionally	NULL
,	NULL
we	NULL
crossed	NULL
our	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
with	NULL
mice	NULL
expressing	NULL
the	NULL
4-hydroxytamoxifen	NULL
(	NULL
4-OHT	NULL
)	NULL
-dependent	NULL
c-MycER	NULL
``	NULL
*	NULL
``	NULL
protein	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
proximal	NULL
ick	NULL
promoter	NULL
.	NULL

Both	NULL
/ck-Madl1	NULL
and	NULL
lIck-oomycER	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
possess	NULL
similar	NULL
copy	NULL
numbers	NULL
of	NULL
their	NULL
requisite	NULL
transgene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
Rudolph	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Lck-c-mycER	NULL
``	NULL
``	NULL
/Ick-Mad1	NULL
double	NULL
transgenic	NULL
mice	NULL
as	NULL
well	NULL
as	NULL
single	NULL
transgenic	NULL
and	NULL
control	NULL
littermates	NULL
were	NULL
injected	NULL
with	NULL
4-hydroxytamoxifen	NULL
(	NULL
4-0O0HT	NULL
)	NULL
to	NULL
activate	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
A	NULL
.	NULL

B.	NULL
C.	NULL
undivided	NULL
divided	NULL
&	NULL
s	NULL
a	NULL
s	NULL
51	NULL
a	NULL
#	NULL
1	NULL
#	NULL
4	NULL
§	NULL
]	NULL
a	NULL
s	NULL
a	NULL
sq	NULL
5	NULL
wt	NULL
|	NULL
;	NULL
H	NULL
,	NULL
A	NULL
s	NULL
e	NULL
s	NULL
cam	NULL
a	NULL
}	NULL
lak	NULL
6	NULL
4	NULL
|§|	NULL
[	NULL
_	NULL
4	NULL
40	NULL
TH	NULL
03	NULL
24	NULL
w	NULL
4	NULL
wI	NULL
QI—uo	NULL
To	NULL
!	NULL

e	NULL
Mo	NULL
100	NULL
D100	NULL
10	NULL
16	NULL
10°	NULL
105	NULL
°	NULL
200	NULL
``	NULL
~	NULL
abo	NULL
0	NULL
sue	NULL
=	NULL
su0	NULL
=-	NULL
1000	NULL
0	NULL
soo	NULL
-_	NULL
10ho	NULL
Fik	NULL
g	NULL
2	NULL
e	NULL
2	NULL
a	NULL
#	NULL
1	NULL
€4	NULL
€	NULL
24	NULL
o	NULL
21	NULL
sk	NULL
&	NULL
#	NULL
51	NULL
(	NULL
3	NULL
4	NULL
18	NULL
cam	NULL
1	NULL
|o1j8	NULL
62	NULL
Mad1	NULL
a	NULL
]	NULL
J	NULL
H4H2	NULL
&	NULL
]	NULL
a	NULL
|_|H|_	NULL
’	NULL
f	NULL
’	NULL
l	NULL
a3	NULL
54	NULL
``	NULL
--	NULL
-e	NULL
E	NULL
|	NULL
f	NULL
f	NULL
f	NULL
ke	NULL
a-	NULL
8	NULL
‘	NULL
ei	NULL
24	NULL
24	NULL
ed	NULL
©	NULL
Tf	NULL
wo	NULL
mo	NULL
mea	NULL
1°	NULL
10	NULL
!	NULL

*	NULL
t	NULL
10	NULL
``	NULL
CC	NULL
2	NULL
-	NULL
abo	NULL
0	NULL
of	NULL
=	NULL
ao	NULL
0	NULL
ideo	NULL
0	NULL
ao	NULL
--	NULL
alo	NULL
-	NULL
sho	NULL
-	NULL
soo	NULL
-	NULL
tooo	NULL
CFSE	NULL
Hoechst	NULL
33432	NULL
25	NULL
30	NULL
35	NULL
wt	NULL
-	NULL
Madl	NULL
M	NULL
N	NULL
D	NULL
M	NULL
N	NULL
D	NULL
M	NULL
N	NULL
D	NULL
1°	NULL
190	NULL
369	NULL
%	NULL
wt	NULL
-	NULL
Mad1	NULL
we	NULL
-	NULL
Madl	NULL
Prete	NULL
?	NULL

ei	NULL
814	NULL
.	NULL

863	NULL
%	NULL
ai	NULL
601	NULL
594	NULL
%	NULL
)	NULL
4	NULL
194	NULL
127	NULL
%	NULL
3	NULL
103	NULL
-	NULL
59	NULL
%	NULL
8	NULL
215	NULL
207	NULL
%	NULL
5	NULL
39	NULL
155	NULL
%	NULL
GAM	NULL
77	NULL
64	NULL
%	NULL
GM	NULL
181°	NULL
195	NULL
%	NULL
6	NULL
153	NULL
106	NULL
%	NULL
Figure	NULL
6	NULL
Expression	NULL
of	NULL
Madl	NULL
in	NULL
T	NULL
cells	NULL
blocks	NULL
only	NULL
the	NULL
first	NULL
GO-S	NULL
phase	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
but	NULL
not	NULL
subsequent	NULL
cell	NULL
cycles	NULL
.	NULL

(	NULL
a	NULL
)	NULL
1	NULL
x	NULL
10°	NULL
CFSE-stained	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
plated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
immobilized	NULL
anti-CD3/CD28	NULL
antibody	NULL
for	NULL
72	NULL
h	NULL
followed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Representative	NULL
CFSE	NULL
flow	NULL
cytometric	NULL
profiles	NULL
are	NULL
shown	NULL
from	NULL
non-stimulated	NULL
T	NULL
cells	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
and	NULL
from	NULL
anti-CD3/CD28	NULL
co-stimulated	NULL
T	NULL
cells	NULL
(	NULL
thin	NULL
line	NULL
)	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
.	NULL

The	NULL
successive	NULL
peaks	NULL
visible	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/	NULL
CD28	NULL
treatment	NULL
represent	NULL
a	NULL
cell	NULL
population	NULL
which	NULL
has	NULL
divided	NULL
a	NULL
certain	NULL
number	NULL
of	NULL
times	NULL
.	NULL

The	NULL
relative	NULL
size	NULL
of	NULL
each	NULL
peak	NULL
is	NULL
shown	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
alive	NULL
cells	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
b	NULL
)	NULL
CFSE	NULL
stained	NULL
,	NULL
purified	NULL
and	NULL
anti-CD3/CD28	NULL
activated	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
were	NULL
sorted	NULL
by	NULL
setting	NULL
a	NULL
gate	NULL
on	NULL
the	NULL
fourth	NULL
peak	NULL
in	NULL
the	NULL
CFSE	NULL
flow	NULL
cytometric	NULL
profile	NULL
sorting	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
divided	NULL
three	NULL
times	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
activation	NULL
.	NULL

The	NULL
sorted	NULL
T	NULL
cells	NULL
were	NULL
replated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
immobilized	NULL
anti-CD3/CD28	NULL
antibody	NULL
.	NULL

The	NULL
thin	NULL
line	NULL
shows	NULL
the	NULL
CFSE	NULL
flow	NULL
cytometric	NULL
profile	NULL
of	NULL
sorted	NULL
wild-type	NULL
and	NULL
Madl	NULL
T	NULL
cells	NULL
after	NULL
another	NULL
24	NULL
h	NULL
in	NULL
culture	NULL
.	NULL

The	NULL
profile	NULL
of	NULL
the	NULL
originally	NULL
sorted	NULL
T	NULL
cell	NULL
population	NULL
is	NULL
superimposed	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
shows	NULL
RT-PCR	NULL
analysis	NULL
for	NULL
Madl	NULL
expression	NULL
in	NULL
non-divided	NULL
(	NULL
N	NULL
)	NULL
and	NULL
divided	NULL
(	NULL
D	NULL
)	NULL
T	NULL
cells	NULL
after	NULL
25	NULL
,	NULL
30	NULL
and	NULL
35	NULL
cycles	NULL
of	NULL
RT-PCR	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
¢	NULL
)	NULL
1	NULL
x	NULL
10°	NULL
CFSE	NULL
stained	NULL
,	NULL
purified	NULL
and	NULL
anti-CD3/	NULL
CD28-activated	NULL
T	NULL
cells	NULL
from	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
/ck-Mad	NULL
!	NULL

transgenic	NULL
mice	NULL
(	NULL
Madl	NULL
)	NULL
were	NULL
stained	NULL
with	NULL
Hoechst	NULL
33342	NULL
followed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

A	NULL
gate	NULL
was	NULL
set	NULL
using	NULL
the	NULL
CFSE	NULL
profile	NULL
shown	NULL
in	NULL
(	NULL
a	NULL
)	NULL
on	NULL
non-divided	NULL
T	NULL
cells	NULL
(	NULL
peak	NULL
1	NULL
)	NULL
and	NULL
on	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
divided	NULL
once	NULL
(	NULL
peak	NULL
2	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
Hoechst	NULL
33342	NULL
cell	NULL
cycle	NULL
profiles	NULL
were	NULL
analysed	NULL
.	NULL

Flow	NULL
cytometric	NULL
profiles	NULL
from	NULL
undivided	NULL
T	NULL
cells	NULL
(	NULL
e	NULL
left	NULL
)	NULL
and	NULL
profiles	NULL
from	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
divided	NULL
once	NULL
(	NULL
¢	NULL
right	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
experiments	NULL
is	NULL
shown	NULL
1171	NULL
c-MycERY	NULL
in	NULL
vivo	NULL
.	NULL

After	NULL
9-12	NULL
days	NULL
of	NULL
daily	NULL
4-OHT	NULL
administration	NULL
,	NULL
mice	NULL
were	NULL
analysed	NULL
for	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
activation	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
from	NULL
double	NULL
transgenic	NULL
Ick-o-mycER	NULL
``	NULL
/lIck-Mad1	NULL
mice	NULL
and	NULL
their	NULL
control	NULL
littermates	NULL
were	NULL
CFSE	NULL
stained	NULL
and	NULL
stimulated	NULL
with	NULL
anti-CD3/CD28	NULL
for	NULL
72	NULL
h.	NULL
When	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
the	NULL
stimulated	NULL
T	NULL
cells	NULL
from	NULL
Ick-comycER	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
(	NULL
Figure	NULL
7b	NULL
)	NULL
exhibited	NULL
increased	NULL
proliferation	NULL
relative	NULL
to	NULL
cells	NULL
from	NULL
a	NULL
wild-type	NULL
control	NULL
littermate	NULL
(	NULL
Figure	NULL
7a	NULL
)	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
the	NULL
Ick-oompycER	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
is	NULL
therefore	NULL
opposite	NULL
to	NULL
that	NULL
shown	NULL
by	NULL
transgenic	NULL
mice	NULL
which	NULL
show	NULL
less	NULL
proliferation	NULL
compared	NULL
to	NULL
a	NULL
wild-type	NULL
control	NULL
after	NULL
anti-CD3/CD28	NULL
activation	NULL
(	NULL
Figures	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
single	NULL
transgenic	NULL
mice	NULL
,	NULL
T	NULL
cells	NULL
from	NULL
Ick-oomycER/Ick-Mad1	NULL
double	NULL
transgenic	NULL
mice	NULL
injected	NULL
with	NULL
4-OHT	NULL
showed	NULL
a	NULL
proliferation	NULL
profile	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Ick-comycER	NULL
transgenic	NULL
mice	NULL
(	NULL
Figure	NULL
7c¢	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
activation	NULL
of	NULL
c-mye	NULL
in	NULL
vivo	NULL
can	NULL
overcome	NULL
the	NULL
suppression	NULL
of	NULL
proliferation	NULL
caused	NULL
by	NULL
Madl	NULL
expression	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
absolutely	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
4-OHT	NULL
since	NULL
T	NULL
cells	NULL
from	NULL
double	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
c-mye	NULL
was	NULL
not	NULL
activated	NULL
(	NULL
oil	NULL
injection	NULL
)	NULL
showed	NULL
a	NULL
proliferation	NULL
profile	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
Ick-Mad	NULL
!	NULL

l	NULL
transgenic	NULL
littermates	NULL
(	NULL
Figure	NULL
7d	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
Myc	NULL
and	NULL
Madl	NULL
compete	NULL
on	NULL
the	NULL
same	NULL
pathway	NULL
though	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possiblity	NULL
that	NULL
Myc	NULL
simply	NULL
acts	NULL
downstream	NULL
of	NULL
Madl	NULL
in	NULL
a	NULL
completely	NULL
independent	NULL
way	NULL
.	NULL

Oncogene	NULL
a	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
1172	NULL
D.	NULL
MyeER®M/Madl	NULL
+	NULL
4.0HT	NULL
_	NULL
MycERIMU/Madi	NULL
+08	NULL
A	NULL
.	NULL

B.	NULL
C.	NULL
vt	NULL
+4.0HT	NULL
MyeERIM	NULL
+	NULL
4.087	NULL
|	NULL
[	NULL
..-	NULL
-FRfRHE	NULL
g	NULL
f	NULL
#	NULL
b	NULL
.	NULL

24	NULL
1	NULL
c.	NULL
€	NULL
A	NULL
@	NULL
)	NULL
i	NULL
189	NULL
Tw	NULL
196	NULL
)	NULL
!	NULL

wa	NULL
T	NULL
o	NULL
l	NULL
;	NULL
T	NULL
d.	NULL
a.	NULL
b.	NULL
oc	NULL
.	NULL

d.	NULL
1	NULL
201	NULL
137	NULL
119	NULL
501	NULL
%	NULL
2	NULL
104	NULL
101	NULL
80	NULL
111	NULL
%	NULL
3	NULL
168	NULL
208	NULL
157	NULL
110	NULL
%	NULL
4	NULL
208	NULL
249	NULL
218	NULL
134	NULL
%	NULL
5	NULL
M4	NULL
209	NULL
229	NULL
90	NULL
%	NULL
6112	NULL
98	NULL
191	NULL
22	NULL
%	NULL
wo	NULL
af	NULL
as	NULL
ow	NULL
ont	NULL
CFSE	NULL
Figure	NULL
7	NULL
c-Myc	NULL
can	NULL
overcome	NULL
the	NULL
proliferation	NULL
block	NULL
caused	NULL
by	NULL
Madl	NULL
expression	NULL
.	NULL

Purified	NULL
splenic	NULL
T	NULL
cells	NULL
from	NULL
4-OHT-injected	NULL
control	NULL
littermates	NULL
(	NULL
wt	NULL
)	NULL
,	NULL
ick-Mad	NULL
!	NULL

1	NULL
transgenic	NULL
mice	NULL
(	NULL
Mad1	NULL
)	NULL
,	NULL
ick-c-mycER	NULL
``	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
(	NULL
MycER	NULL
``	NULL
**	NULL
``	NULL
)	NULL
and	NULL
double	NULL
transgenic	NULL
/ck-c-transgenic	NULL
mice	NULL
were	NULL
CFSE	NULL
stained	NULL
and	NULL
plated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
immobilized	NULL
anti-CD3/CD28	NULL
antibody	NULL
.	NULL

Seventy-two	NULL
hours	NULL
after	NULL
plating	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
result	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
Discussion	NULL
Madl	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
bHLHZip	NULL
protein	NULL
identified	NULL
through	NULL
interaction	NULL
with	NULL
Max	NULL
,	NULL
the	NULL
common	NULL
partner	NULL
in	NULL
the	NULL
Myc/Max/Madl1	NULL
network	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
Mad	NULL
proteins	NULL
antagonize	NULL
functionally	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
Myc	NULL
protein	NULL
family	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Hurlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
is	NULL
based	NULL
upon	NULL
three	NULL
in	NULL
vitro	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Madl	NULL
to	NULL
compete	NULL
with	NULL
Myc	NULL
for	NULL
binding	NULL
to	NULL
its	NULL
partner	NULL
protein	NULL
Max	NULL
;	NULL
second	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Madl1/Max	NULL
heterodimers	NULL
to	NULL
compete	NULL
with	NULL
Myc/Max	NULL
heterodimers	NULL
for	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
sites	NULL
and	NULL
third	NULL
the	NULL
opposing	NULL
transcriptional	NULL
activities	NULL
of	NULL
Mad1	NULL
and	NULL
Myc	NULL
as	NULL
repressor	NULL
and	NULL
activator	NULL
,	NULL
respectively	NULL
.	NULL

If	NULL
these	NULL
in	NULL
vitro	NULL
data	NULL
hold	NULL
true	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
would	NULL
presume	NULL
that	NULL
transgenic	NULL
expression	NULL
of	NULL
Ick-Mad1	NULL
would	NULL
antagonize	NULL
the	NULL
function	NULL
of	NULL
endogenous	NULL
c-myc	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Amati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
as	NULL
yet	NULL
no	NULL
evidence	NULL
that	NULL
Madl	NULL
can	NULL
suppress	NULL
Myc	NULL
action	NULL
in	NULL
vivo	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Mad	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
potent	NULL
transcriptional	NULL
repressors	NULL
,	NULL
exert	NULL
other	NULL
functions	NULL
in	NULL
addition	NULL
to	NULL
antagonizing	NULL
Myc	NULL
.	NULL

We	NULL
therefore	NULL
decided	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
perturbing	NULL
the	NULL
Myc/Max/Madl1	NULL
network	NULL
in	NULL
vivo	NULL
by	NULL
transgenic	NULL
expression	NULL
of	NULL
Madl	NULL
in	NULL
thymus	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
-	NULL
tissues	NULL
in	NULL
which	NULL
ontogeny	NULL
,	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
,	NULL
all	NULL
important	NULL
attributes	NULL
of	NULL
the	NULL
Myc/Max/Mad1	NULL
network	NULL
,	NULL
play	NULL
important	NULL
parts	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
one	NULL
existing	NULL
study	NULL
has	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
transgenic	NULL
expression	NULL
of	NULL
Max	NULL
under	NULL
control	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enchancer	NULL
(	NULL
E	NULL
)	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
shown	NULL
that	NULL
Max	NULL
attenuates	NULL
Myc-induced	NULL
lympho-proliferation	NULL
and	NULL
lymphomagenesis	NULL
in	NULL
Myc/Max	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
Lindemann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
Max	NULL
is	NULL
the	NULL
central	NULL
shared	NULL
component	NULL
within	NULL
the	NULL
Myc/Max/Mad1	NULL
network	NULL
,	NULL
it	NULL
has	NULL
the	NULL
capability	NULL
of	NULL
enhancing	NULL
not	NULL
only	NULL
Myc	NULL
but	NULL
also	NULL
Madl	NULL
activity	NULL
,	NULL
making	NULL
interpretation	NULL
of	NULL
this	NULL
study	NULL
difficult	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
Madl	NULL
protein	NULL
in	NULL
vivo	NULL
by	NULL
generating	NULL
transgenic	NULL
mice	NULL
expressing	NULL
Madl	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
specific	NULL
proximal	NULL
/ck	NULL
promoter	NULL
.	NULL

Perhaps	NULL
surprisingly	NULL
,	NULL
Oncogene	NULL
these	NULL
mice	NULL
display	NULL
apparently	NULL
normal	NULL
T	NULL
cell	NULL
development	NULL
with	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
representation	NULL
of	NULL
various	NULL
thymocyte	NULL
sub	NULL
populations	NULL
.	NULL

This	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
findings	NULL
of	NULL
a	NULL
recent	NULL
study	NULL
in	NULL
which	NULL
Max	NULL
was	NULL
transgenically	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
immunoglobulin	NULL
Ep	NULL
heavy	NULL
chain	NULL
enchancer	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
different	NULL
T	NULL
cell	NULL
sub	NULL
populations	NULL
appeared	NULL
normal	NULL
in	NULL
Epu-Max	NULL
mice	NULL
(	NULL
Lindemann	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
robust	NULL
homeostasis	NULL
of	NULL
T	NULL
lymphocyte	NULL
development	NULL
,	NULL
even	NULL
in	NULL
the	NULL
face	NULL
of	NULL
major	NULL
experimental	NULL
genetic	NULL
manipulation	NULL
,	NULL
is	NULL
well	NULL
acknowledged	NULL
even	NULL
though	NULL
its	NULL
basis	NULL
remains	NULL
a	NULL
mystery	NULL
.	NULL

To	NULL
analyse	NULL
the	NULL
effect	NULL
of	NULL
/ck-Madl1	NULL
expression	NULL
on	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
detail	NULL
,	NULL
we	NULL
used	NULL
the	NULL
H-Y-TCR	NULL
model	NULL
for	NULL
T	NULL
cell	NULL
selection	NULL
(	NULL
von	NULL
Boehmer	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Our	NULL
analysis	NULL
indicates	NULL
that	NULL
deregulated	NULL
Madl	NULL
expression	NULL
exerts	NULL
effects	NULL
on	NULL
positive	NULL
thymocyte	NULL
selection	NULL
reducing	NULL
the	NULL
efficiency	NULL
of	NULL
the	NULL
generation	NULL
of	NULL
CD8*	NULL
SP	NULL
.	NULL

One	NULL
obvious	NULL
feature	NULL
of	NULL
the	NULL
Ick-Mad1-transgenic	NULL
mice	NULL
was	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
lymphoid	NULL
cellularity	NULL
,	NULL
accompanied	NULL
by	NULL
an	NULL
impaired	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
or	NULL
PMA	NULL
treatment	NULL
in	NULL
vitro	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
reduced	NULL
in	NULL
vivo	NULL
lymphoid	NULL
cellularity	NULL
induced	NULL
by	NULL
Madl	NULL
expression	NULL
arises	NULL
by	NULL
inhibition	NULL
of	NULL
proliferation	NULL
during	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
thymocyte	NULL
proliferation	NULL
.	NULL

The	NULL
block	NULL
in	NULL
proliferation	NULL
observed	NULL
in	NULL
ick-Mad	NULL
!	NULL

l	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
recently	NULL
published	NULL
report	NULL
showing	NULL
increased	NULL
proliferation	NULL
of	NULL
mxi-'~-	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
treatment	NULL
(	NULL
Schreiber-Agus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
matched	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
mxi-'-	NULL
splenic	NULL
T	NULL
cells	NULL
exiting	NULL
from	NULL
G1	NULL
phase	NULL
.	NULL

As	NULL
might	NULL
be	NULL
expected	NULL
from	NULL
the	NULL
broad	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
Myc	NULL
and	NULL
Mad	NULL
proteins	NULL
,	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
Mad1	NULL
expression	NULL
on	NULL
proliferation	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
Madl	NULL
inhibits	NULL
NIH3T3	NULL
cell	NULL
line	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
CSF-1	NULL
receptor	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
the	NULL
fraction	NULL
of	NULL
G1	NULL
phase	NULL
cells	NULL
(	NULL
Roussel	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
whereas	NULL
cell	NULL
cycle	NULL
exit	NULL
of	NULL
granulocytic	NULL
precursors	NULL
from	NULL
Mad-'~-	NULL
mice	NULL
is	NULL
inhibited	NULL
relative	NULL
to	NULL
control	NULL
cells	NULL
(	NULL
Foley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
growth-inhibitory	NULL
effect	NULL
of	NULL
Madl	NULL
we	NULL
observe	NULL
on	NULL
thymocytes	NULL
is	NULL
overcome	NULL
by	NULL
co-expression	NULL
of	NULL
c-Myc	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
Myc	NULL
and	NULL
Mad	NULL
compete	NULL
for	NULL
their	NULL
antagonistic	NULL
functions	NULL
on	NULL
cell	NULL
proliferation	NULL
.	NULL

What	NULL
might	NULL
be	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Madl	NULL
expression	NULL
suppresses	NULL
thymocyte	NULL
proliferation	NULL
?	NULL

Initiation	NULL
of	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
involves	NULL
activation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
and	NULL
the	NULL
CD28	NULL
co-receptor	NULL
by	NULL
antigens	NULL
or	NULL
activating	NULL
antibodies	NULL
which	NULL
initiates	NULL
an	NULL
intracellular	NULL
cascade	NULL
of	NULL
signalling	NULL
events	NULL
culminating	NULL
in	NULL
activation	NULL
of	NULL
critical	NULL
genes	NULL
such	NULL
as	NULL
c-myc	NULL
and	NULL
IL-2	NULL
that	NULL
are	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Autocrine	NULL
stimulation	NULL
by	NULL
IL-2	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
Tcell	NULL
proliferation	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
one	NULL
effect	NULL
of	NULL
Madl	NULL
expression	NULL
might	NULL
be	NULL
the	NULL
inhibition	NULL
of	NULL
IL-2	NULL
synthesis	NULL
or	NULL
secretion	NULL
.	NULL

However	NULL
,	NULL
this	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
the	NULL
case	NULL
since	NULL
addition	NULL
of	NULL
recombinant	NULL
IL-2	NULL
to	NULL
antiCD3/CD28	NULL
stimulated	NULL
/Ick-Mad1	NULL
transgenic	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
failed	NULL
to	NULL
restore	NULL
proliferation	NULL
to	NULL
normal	NULL
levels	NULL
.	NULL

A	NULL
similar	NULL
observation	NULL
has	NULL
also	NULL
been	NULL
made	NULL
in	NULL
mice	NULL
expressing	NULL
IxB	NULL
«	NULL
or	NULL
FADD	NULL
DN	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
proximal	NULL
ick	NULL
promoter	NULL
(	NULL
Boothby	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Zoernig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
also	NULL
show	NULL
a	NULL
profound	NULL
block	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
block	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
/ck-Mad	NULL
!	NULL

l	NULL
transgenic	NULL
mice	NULL
,	NULL
we	NULL
analysed	NULL
the	NULL
behaviour	NULL
of	NULL
a	NULL
number	NULL
of	NULL
key	NULL
molecules	NULL
implicated	NULL
in	NULL
G1	NULL
phase	NULL
cell	NULL
cycle	NULL
progres-sion	NULL
.	NULL

Activation	NULL
of	NULL
Myc	NULL
in	NULL
arrested	NULL
RATIA-MycER	NULL
fibroblasts	NULL
stimulates	NULL
expression	NULL
of	NULL
both	NULL
cyclin	NULL
E	NULL
and	NULL
cyclin	NULL
A	NULL
(	NULL
Janser-Duerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
S	NULL
phase	NULL
entry	NULL
is	NULL
preceded	NULL
by	NULL
increased	NULL
levels	NULL
of	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
activity	NULL
(	NULL
Steiner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
thymocytes	NULL
from	NULL
our	NULL
/ck-Madl	NULL
transgenic	NULL
mice	NULL
,	NULL
kinetics	NULL
and	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
G1	NULL
phase	NULL
cedks	NULL
,	NULL
cyclins	NULL
and	NULL
the	NULL
cdk	NULL
inhibitors	NULL
p21	NULL
and	NULL
p27	NULL
in	NULL
response	NULL
to	NULL
anti-CD3/CD28	NULL
treatment	NULL
all	NULL
appeared	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
control	NULL
thymocytes	NULL
.	NULL

Only	NULL
cyclin	NULL
A	NULL
,	NULL
a	NULL
typical	NULL
S	NULL
phase	NULL
cyclin	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
altered	NULL
in	NULL
/Ick-Mad	NULL
!	NULL

thymocytes	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
block	NULL
in	NULL
cell	NULL
cycle	NULL
progression	NULL
at	NULL
the	NULL
transition	NULL
from	NULL
G1	NULL
into	NULL
S	NULL
phase	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
Mad	NULL
proteins	NULL
function	NULL
to	NULL
regulate	NULL
cell	NULL
growth	NULL
by	NULL
regulating	NULL
the	NULL
exit	NULL
from	NULL
G1	NULL
phase	NULL
(	NULL
Roussel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Foley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
Mad1-induced	NULL
growth	NULL
arrest	NULL
might	NULL
be	NULL
p53-dependent	NULL
.	NULL

However	NULL
,	NULL
loss	NULL
of	NULL
p53	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
Mad	NULL
to	NULL
suppress	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
p53	NULL
also	NULL
did	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
required	NULL
for	NULL
Myc-induced	NULL
proliferation	NULL
.	NULL

Consistently	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
c-mye	NULL
induces	NULL
proliferation	NULL
in	NULL
p53-~-	NULL
MEFs	NULL
(	NULL
Hermeking	NULL
and	NULL
Eick	NULL
,	NULL
1994	NULL
;	NULL
Wagner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
proteins	NULL
of	NULL
the	NULL
Myc/Max/Mad1	NULL
network	NULL
and	NULL
p53	NULL
is	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
p53	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
mediating	NULL
Myc-induced	NULL
apoptosis	NULL
(	NULL
Hsu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
although	NULL
this	NULL
probably	NULL
reflects	NULL
synergy	NULL
between	NULL
the	NULL
two	NULL
rather	NULL
than	NULL
a	NULL
dependence	NULL
of	NULL
one	NULL
on	NULL
the	NULL
other	NULL
(	NULL
Juin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
mice	NULL
transgenically	NULL
expressing	NULL
c-myc	NULL
on	NULL
a	NULL
p53	NULL
negative	NULL
background	NULL
show	NULL
accelerated	NULL
development	NULL
of	NULL
malignant	NULL
lymphomas	NULL
(	NULL
Hsu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Elson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
a	NULL
The	NULL
notion	NULL
that	NULL
Madl	NULL
can	NULL
act	NULL
as	NULL
a	NULL
p53-independent	NULL
tumor	NULL
suppressor	NULL
is	NULL
an	NULL
intriguing	NULL
one	NULL
that	NULL
has	NULL
never	NULL
been	NULL
tested	NULL
directly	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
observations	NULL
that	NULL
support	NULL
the	NULL
idea	NULL
.	NULL

First	NULL
,	NULL
Madl	NULL
suppresses	NULL
c-myc-induced	NULL
transformation	NULL
in	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
(	NULL
Lahoz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
madl	NULL
maps	NULL
to	NULL
a	NULL
chromosomal	NULL
region	NULL
altered	NULL
in	NULL
certain	NULL
human	NULL
tumors	NULL
(	NULL
Edelhoff	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
an	NULL
adenovirus	NULL
vector	NULL
encoding	NULL
Madl	NULL
dramatically	NULL
inhibits	NULL
the	NULL
tumorigenicity	NULL
of	NULL
human	NULL
astrocytoma	NULL
cells	NULL
in	NULL
nude	NULL
mice	NULL
(	NULL
Chen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
manipulation	NULL
of	NULL
Mad	NULL
family	NULL
members	NULL
may	NULL
be	NULL
an	NULL
effective	NULL
way	NULL
of	NULL
suppressing	NULL
cell	NULL
growth	NULL
even	NULL
in	NULL
tumors	NULL
lacking	NULL
functional	NULL
p53	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Generation	NULL
of	NULL
transgenic	NULL
mice	NULL
A	NULL
cDNA	NULL
encoding	NULL
human	NULL
Madl	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
cloning	NULL
site	NULL
of	NULL
the	NULL
transgenic	NULL
expression	NULL
vector	NULL
p1070	NULL
(	NULL
Chaffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
/ck-Mad	NULL
!	NULL

transgene	NULL
was	NULL
microinjected	NULL
into	NULL
the	NULL
male	NULL
pronucleus	NULL
of	NULL
fertilised	NULL
C57BL/6/CBA	NULL
F1	NULL
embryos	NULL
.	NULL

Injected	NULL
embryos	NULL
were	NULL
transferred	NULL
into	NULL
pseudo-pregnant	NULL
foster	NULL
mice	NULL
.	NULL

Transgenic	NULL
founders	NULL
were	NULL
detected	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
hgh	NULL
)	NULL
probe	NULL
to	NULL
detect	NULL
the	NULL
transgenic	NULL
construct	NULL
.	NULL

Two	NULL
independent	NULL
Mad	NULL
!	NULL

transgenic	NULL
lines	NULL
were	NULL
established	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
[	NULL
Ick-c-mycER	NULL
``	NULL
``	NULL
transgenic	NULL
mice	NULL
is	NULL
described	NULL
elsewhere	NULL
(	NULL
Rudolph	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

H-Y-TCR	NULL
transgenic	NULL
mice	NULL
(	NULL
H-2	NULL
``	NULL
``	NULL
)	NULL
were	NULL
originally	NULL
described	NULL
by	NULL
von	NULL
Bochmer	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Offsprings	NULL
from	NULL
-	NULL
/ck-Mad1l	NULL
x	NULL
H-Y-TCR	NULL
crosses	NULL
were	NULL
analysed	NULL
.	NULL

The	NULL
status	NULL
of	NULL
the	NULL
MHC	NULL
locus	NULL
was	NULL
assessed	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
H-Y-TCR	NULL
probe	NULL
(	NULL
Bluthmann	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Mice	NULL
with	NULL
H-2	NULL
``	NULL
*	NULL
status	NULL
were	NULL
analysed	NULL
.	NULL

P53~~-	NULL
mice	NULL
were	NULL
originally	NULL
described	NULL
by	NULL
Donehower	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
activation	NULL
of	NULL
\ck-c-mycER	NULL
``	NULL
Y	NULL
transgene	NULL
In	NULL
vivo	NULL
activation	NULL
of	NULL
Ick-o-mycER	NULL
``	NULL
``	NULL
transgene	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Rudolph	NULL
er	NULL
a/	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

RNA	NULL
expression	NULL
analysis	NULL
Total	NULL
RNA	NULL
from	NULL
thymus	NULL
and	NULL
spleen	NULL
was	NULL
isolated	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
standard	NULL
techniques	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
human	NULL
Madl	NULL
cDNA	NULL
(	NULL
Ayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

For	NULL
RT-PCR	NULL
analysis	NULL
,	NULL
total	NULL
RNA	NULL
from	NULL
sorted	NULL
thymocyte	NULL
sub	NULL
populations	NULL
was	NULL
prepared	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
DNAse	NULL
I	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
treated	NULL
and	NULL
cDNA	NULL
was	NULL
synthesized	NULL
using	NULL
random	NULL
hexamer	NULL
primer	NULL
and	NULL
Superscript	NULL
``	NULL
RNaseH~	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

RT-PCR	NULL
expression	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
Mad1	NULL
,	NULL
Mxi	NULL
,	NULL
Mad4	NULL
and	NULL
Bactin	NULL
.	NULL

(	NULL
Mad1	NULL
:	NULL
5'-CTCTGATAGAGAAGAACTGGACG-3	NULL
'	NULL
,	NULL
5-TCGTCCGA-GTCACTCACGCTG-3	NULL
'	NULL
,	NULL
Mxi	NULL
:	NULL
S5-ACACTTTTCTGCAGAA-CGTGC-3	NULL
'	NULL
,	NULL
5-TGAGGCGTAGCCATGTTCACA-3	NULL
'	NULL
,	NULL
Mad4	NULL
:	NULL
5S-ACAGGTCTTCACACAACGAAC-3Y	NULL
,	NULL
5-CTCAGAGTA-GTGTGACGTG-3	NULL
'	NULL
)	NULL
.	NULL

Radiolabelled	NULL
amplification	NULL
products	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
non-radioactive	NULL
detection	NULL
of	NULL
Mad1	NULL
expression	NULL
in	NULL
antiCD3/CD28	NULL
stimulated	NULL
,	NULL
sorted	NULL
purified	NULL
T	NULL
cells	NULL
the	NULL
following	NULL
1173	NULL
Oncogene	NULL
a	NULL
Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
1174	NULL
primer	NULL
pair	NULL
was	NULL
used	NULL
:	NULL
5-CGGGCTCATCTITTCGCTTG-3	NULL
,	NULL
5-ACGGTGGAGCGGATGCGTC-3	NULL
.	NULL

Immunohistochemical	NULL
staining	NULL
For	NULL
histological	NULL
examination	NULL
,	NULL
thymus	NULL
tissue	NULL
was	NULL
snap	NULL
frozen	NULL
and	NULL
5	NULL
um	NULL
sections	NULL
were	NULL
prepared	NULL
.	NULL

Madl	NULL
protein	NULL
expression	NULL
was	NULL
detected	NULL
using	NULL
a	NULL
Madl	NULL
specific	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Cell	NULL
surface	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
Flow	NULL
cytometry	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Rudolph	NULL
er	NULL
al	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Western	NULL
immunoblot	NULL
analysis	NULL
Tissues	NULL
were	NULL
lysed	NULL
in	NULL
125	NULL
mm	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
2.5	NULL
%	NULL
SDS	NULL
and	NULL
10	NULL
%	NULL
B-mercaptoethanol	NULL
.	NULL

20	NULL
ug	NULL
protein	NULL
lysate/sample	NULL
was	NULL
used	NULL
for	NULL
Western	NULL
immunoblot	NULL
with	NULL
the	NULL
following	NULL
antibodies	NULL
:	NULL
cyclin	NULL
E	NULL
,	NULL
edk	NULL
2	NULL
,	NULL
edk	NULL
4	NULL
,	NULL
cyclin	NULL
A	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
cyclin	NULL
D2	NULL
and	NULL
D3	NULL
(	NULL
kind	NULL
gifts	NULL
of	NULL
Dr	NULL
Peter	NULL
Parker	NULL
,	NULL
ICRF	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
and	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
Cyclin	NULL
E	NULL
immunoprecipitations	NULL
and	NULL
cyclin	NULL
E-dependent	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
Dulic	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
using	NULL
the	NULL
anti-cyclin	NULL
E	NULL
(	NULL
M20	NULL
)	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
Purification	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
was	NULL
performed	NULL
using	NULL
mouse	NULL
T	NULL
cell	NULL
Enrichment	NULL
Columns	NULL
(	NULL
R	NULL
&	NULL
D	NULL
systems	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
proliferation	NULL
assay	NULL
1x	NULL
10°	NULL
thymocytes	NULL
or	NULL
purified	NULL
splenic	NULL
T	NULL
cells/96-well	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
medium	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
50	NULL
um	NULL
2-mercaptoethanol	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
100	NULL
u/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plate-bound	NULL
anti-CD3/CD28	NULL
antibody	NULL
(	NULL
PharMingen	NULL
:	NULL
10	NULL
ug/ml	NULL
each	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
PMA	NULL
:	NULL
Sigma	NULL
2	NULL
ng/	NULL
ml	NULL
,	NULL
Ionomycin	NULL
:	NULL
Calbiochem	NULL
0.2	NULL
ug/ml	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
thymocytes	NULL
derived	NULL
from	NULL
/ck-c-mycER	NULL
``	NULL
``	NULL
/Mad1	NULL
double	NULL
transgenic	NULL
mice	NULL
or	NULL
their	NULL
control	NULL
littermates	NULL
,	NULL
200	NULL
nM	NULL
4-hydroxytamoxifen	NULL
(	NULL
RBI	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
.	NULL

To	NULL
determine	NULL
IL-2	NULL
dependence	NULL
of	NULL
the	NULL
proliferation	NULL
,	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Chiron	NULL
UK	NULL
:	NULL
20	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

At	NULL
various	NULL
time	NULL
points	NULL
,	NULL
proliferation	NULL
was	NULL
assessed	NULL
by	NULL
adding	NULL
References	NULL
Adams	NULL
JM	NULL
,	NULL
Harris	NULL
AW	NULL
,	NULL
Pinkert	NULL
CA	NULL
,	NULL
Corcoran	NULL
LM	NULL
,	NULL
Alexander	NULL
WS	NULL
,	NULL
Cory	NULL
S	NULL
,	NULL
Palmiter	NULL
RD	NULL
and	NULL
Brinster	NULL
RL	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
318	NULL
,	NULL
533-538	NULL
.	NULL

Albrecht	NULL
JH	NULL
,	NULL
Poon	NULL
RY	NULL
,	NULL
Ahonen	NULL
CL	NULL
,	NULL
Riel	NULL
BM	NULL
,	NULL
Deng	NULL
C	NULL
and	NULL
Crary	NULL
GS	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
16	NULL
,	NULL
2141-2150	NULL
.	NULL

Amati	NULL
B	NULL
,	NULL
Dalton	NULL
S	NULL
,	NULL
Brooks	NULL
M	NULL
,	NULL
Littlewood	NULL
T	NULL
,	NULL
Evan	NULL
G	NULL
and	NULL
Land	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
359	NULL
,	NULL
423-426	NULL
.	NULL

Amati	NULL
B	NULL
and	NULL
Land	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
102-108	NULL
.	NULL

Amati	NULL
B	NULL
,	NULL
Littlewood	NULL
T	NULL
,	NULL
Evan	NULL
GI	NULL
and	NULL
Land	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
5083-5087	NULL
.	NULL

Oncogene	NULL
[	NULL
PH	NULL
]	NULL
-thymidine	NULL
(	NULL
1	NULL
4Ci/96-well	NULL
)	NULL
and	NULL
16	NULL
h	NULL
later	NULL
[	NULL
°H	NULL
]	NULL
-thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
B-plate	NULL
reader	NULL
.	NULL

CFSE	NULL
and	NULL
Hoechst	NULL
33342	NULL
staining	NULL
Purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
fluorescent	NULL
dye	NULL
carboxyfluorescein	NULL
succinimidyl	NULL
ester	NULL
(	NULL
CFSE	NULL
,	NULL
Molecular	NULL
Probes	NULL
)	NULL
(	NULL
Wells	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Lyons	NULL
and	NULL
Parish	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
resuspended	NULL
at	NULL
a	NULL
density	NULL
of	NULL
maximal	NULL
1x	NULL
10	NULL
'	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
0.1	NULL
%	NULL
BSA/PBS	NULL
.	NULL

CFSE	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
uM	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

For	NULL
lymphocyte	NULL
activation	NULL
studies	NULL
,	NULL
CFSE	NULL
labelled	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
24-well	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
immobilised	NULL
anti-CD3/CD28	NULL
antibody	NULL
(	NULL
PharMingen	NULL
:	NULL
10	NULL
ug/	NULL
ml	NULL
each	NULL
)	NULL
.	NULL

Seventy-two	NULL
hours	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
CFSE	NULL
labelled	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

A	NULL
control	NULL
of	NULL
CFSE-stained	NULL
T	NULL
cells	NULL
incubated	NULL
for	NULL
the	NULL
same	NULL
time	NULL
without	NULL
activation	NULL
aided	NULL
identification	NULL
of	NULL
the	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
CFSE	NULL
profile	NULL
that	NULL
had	NULL
not	NULL
divided	NULL
.	NULL

For	NULL
cell	NULL
sorting	NULL
,	NULL
CFSE	NULL
stained	NULL
,	NULL
activated	NULL
T	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
FCS	NULL
,	NULL
soluble	NULL
antiCD3/	NULL
CD28	NULL
antibody	NULL
(	NULL
2	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Chiron	NULL
UK	NULL
:	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
sorting	NULL
,	NULL
1	NULL
x	NULL
10°	NULL
T	NULL
cells	NULL
were	NULL
replated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plate-bound	NULL
anti-CD3/CD28	NULL
antibody	NULL
(	NULL
PharMingen	NULL
:	NULL
10	NULL
ug/ml	NULL
each	NULL
)	NULL
and	NULL
recombinant	NULL
IL-2	NULL
.	NULL

CFSE	NULL
profiles	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

To	NULL
obtain	NULL
a	NULL
Hoechst	NULL
33342	NULL
cell	NULL
cycle	NULL
profile	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
CFSE	NULL
staining	NULL
,	NULL
activated	NULL
,	NULL
CFSE	NULL
stained	NULL
T	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
treated	NULL
with	NULL
Hoechst	NULL
33342	NULL
(	NULL
Hoechst	NULL
;	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

To	NULL
distinguish	NULL
live	NULL
from	NULL
dead	NULL
cells	NULL
,	NULL
propidium	NULL
iodide	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
before	NULL
FACS	NULL
analysis	NULL
.	NULL

CFSE/Hoechst	NULL
profiles	NULL
were	NULL
analysed	NULL
using	NULL
a	NULL
FACSvantage	NULL
dual	NULL
laser	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
T	NULL
Crafton	NULL
and	NULL
her	NULL
team	NULL
for	NULL
excellent	NULL
support	NULL
with	NULL
the	NULL
animal	NULL
work	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
J	NULL
Bee	NULL
and	NULL
G	NULL
Hutchinson	NULL
for	NULL
the	NULL
help	NULL
with	NULL
the	NULL
IP	NULL
injections	NULL
.	NULL

We	NULL
would	NULL
also	NULL
like	NULL
to	NULL
thank	NULL
D	NULL
Davies	NULL
and	NULL
his	NULL
team	NULL
for	NULL
help	NULL
with	NULL
cell	NULL
sorting	NULL
and	NULL
U	NULL
Knies	NULL
for	NULL
technical	NULL
help	NULL
during	NULL
the	NULL
final	NULL
phase	NULL
of	NULL
the	NULL
manuscript	NULL
preparation	NULL
.	NULL

We	NULL
thank	NULL
D	NULL
Cantrell	NULL
for	NULL
critical	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

B	NULL
Rudolph	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
DFG	NULL
Postdoktoranden	NULL
Stipendium	NULL
and	NULL
a	NULL
Marie	NULL
Curie	NULL
TMR	NULL
fellowship	NULL
(	NULL
ERBFMBICT961770	NULL
)	NULL
.	NULL

A-O	NULL
Hueber	NULL
was	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
long-term	NULL
EMBO	NULL
fellowship	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
for	NULL
support	NULL
from	NULL
the	NULL
Royal	NULL
Society	NULL
and	NULL
from	NULL
EC	NULL
BioTech	NULL
Grant	NULL
BIO4-CT96-0052	NULL
.	NULL

Ayer	NULL
DE	NULL
,	NULL
Kretzner	NULL
L	NULL
and	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
72	NULL
,	NULL
211-222	NULL
.	NULL

Ayer	NULL
DE	NULL
,	NULL
Lawrence	NULL
QA	NULL
and	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
767-776	NULL
.	NULL

Backwood	NULL
EM	NULL
,	NULL
Luescher	NULL
B	NULL
and	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
71-80	NULL
.	NULL

Blackwell	NULL
TK	NULL
,	NULL
Kretzner	NULL
L	NULL
,	NULL
Blackwood	NULL
EM	NULL
,	NULL
Eisenman	NULL
RN	NULL
and	NULL
Weintraub	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
250	NULL
,	NULL
1149-1151	NULL
.	NULL

Bluthmann	NULL
H	NULL
,	NULL
Kisielow	NULL
P	NULL
,	NULL
Uematsu	NULL
Y	NULL
,	NULL
Malissen	NULL
M	NULL
,	NULL
Krimpenfort	NULL
P	NULL
,	NULL
Berns	NULL
A	NULL
,	NULL
von	NULL
Boehmer	NULL
H	NULL
and	NULL
Steinmetz	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
334	NULL
,	NULL
156-159	NULL
.	NULL

Boonen	NULL
GJ	NULL
,	NULL
van	NULL
Dijk	NULL
AM	NULL
,	NULL
Verdonck	NULL
LF	NULL
,	NULL
van	NULL
Lier	NULL
RA	NULL
,	NULL
Rijksen	NULL
G	NULL
and	NULL
Medem	NULL
RH	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
29	NULL
,	NULL
789-798	NULL
.	NULL

Boothby	NULL
MR	NULL
,	NULL
Mora	NULL
AL	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
Brockman	NULL
JA	NULL
and	NULL
Ballard	NULL
DW	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
185	NULL
,	NULL
1897-1907	NULL
.	NULL

Brinster	NULL
RL	NULL
,	NULL
Chen	NULL
HY	NULL
,	NULL
Trumbauer	NULL
ME	NULL
,	NULL
Yagle	NULL
MK	NULL
and	NULL
Palmiter	NULL
RD	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
,	NULL
4438-4442	NULL
.	NULL

Broussard-Diehl	NULL
C	NULL
,	NULL
Bauer	NULL
SR	NULL
and	NULL
Scheuermann	NULL
RH	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
156	NULL
,	NULL
3141-3150	NULL
.	NULL

Carding	NULL
S	NULL
and	NULL
Reem	NULL
GH	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Thymus	NULL
,	NULL
10	NULL
,	NULL
219-229	NULL
.	NULL

Chaffin	NULL
KE	NULL
,	NULL
Beals	NULL
CR	NULL
,	NULL
Wilkie	NULL
TM	NULL
,	NULL
Forbusch	NULL
KA	NULL
,	NULL
Simon	NULL
MI	NULL
and	NULL
Perlmutter	NULL
RM	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
3821-3829	NULL
.	NULL

Chen	NULL
J	NULL
,	NULL
Willingham	NULL
TL	NULL
,	NULL
Margraf	NULL
R	NULL
,	NULL
Schreiber-Agus	NULL
N	NULL
,	NULL
DePinho	NULL
RA	NULL
and	NULL
Nisen	NULL
PD	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
Med	NULL
.	NULL

,	NULL
1	NULL
,	NULL
638	NULL
643	NULL
.	NULL

Davis	NULL
AC	NULL
,	NULL
Wims	NULL
M	NULL
,	NULL
Spotts	NULL
GD	NULL
,	NULL
Hann	NULL
SR	NULL
and	NULL
Bradley	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
671-682	NULL
.	NULL

Donehower	NULL
LA	NULL
,	NULL
Harvey	NULL
M	NULL
,	NULL
Slagle	NULL
BL	NULL
,	NULL
McArthur	NULL
MJ	NULL
,	NULL
Montgomery	NULL
Jr	NULL
CA	NULL
,	NULL
Butel	NULL
JS	NULL
and	NULL
Bradley	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
356	NULL
,	NULL
215-221	NULL
.	NULL

Dulic	NULL
V	NULL
,	NULL
Kaufmann	NULL
WK	NULL
,	NULL
Wilson	NULL
SJ	NULL
,	NULL
Tilsty	NULL
TD	NULL
,	NULL
Lees	NULL
E	NULL
,	NULL
Harper	NULL
JW	NULL
,	NULL
Elledge	NULL
SJ	NULL
and	NULL
Reed	NULL
SI	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
1013-1023	NULL
.	NULL

Edelhoff	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
665-668	NULL
.	NULL

Eilers	NULL
M	NULL
,	NULL
Schirm	NULL
S	NULL
and	NULL
Bishop	NULL
JM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
133-141	NULL
.	NULL

Elson	NULL
A	NULL
,	NULL
Deng	NULL
C	NULL
,	NULL
Campos-Torres	NULL
J	NULL
,	NULL
Donehowder	NULL
LA	NULL
and	NULL
Leder	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
11	NULL
,	NULL
181-190	NULL
.	NULL

Evan	NULL
GI	NULL
,	NULL
Wyllie	NULL
AH	NULL
,	NULL
Gilbert	NULL
CS	NULL
,	NULL
Littlewood	NULL
TD	NULL
,	NULL
Land	NULL
H	NULL
,	NULL
Brooks	NULL
M	NULL
,	NULL
Waters	NULL
CM	NULL
,	NULL
Penn	NULL
LZ	NULL
and	NULL
Hancock	NULL
DC	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
63	NULL
,	NULL
119-125	NULL
.	NULL

Foley	NULL
KP	NULL
,	NULL
McArthur	NULL
GA	NULL
,	NULL
Queva	NULL
C	NULL
,	NULL
Hurlin	NULL
PJ	NULL
,	NULL
Soriano	NULL
P	NULL
and	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
,	NULL
774-785	NULL
.	NULL

Heikkila	NULL
R	NULL
,	NULL
Schwab	NULL
G	NULL
,	NULL
Wickstrom	NULL
E	NULL
,	NULL
Loke	NULL
S	NULL
,	NULL
Pulznik	NULL
D	NULL
,	NULL
Watt	NULL
R	NULL
and	NULL
Neckers	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
328	NULL
,	NULL
445-448	NULL
.	NULL

Hermeking	NULL
H	NULL
and	NULL
Eick	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
265	NULL
,	NULL
2091-2093	NULL
.	NULL

Hsu	NULL
B	NULL
,	NULL
Marin	NULL
MC	NULL
,	NULL
El-Naggar	NULL
AK	NULL
,	NULL
Stephens	NULL
LS	NULL
,	NULL
Brisby	NULL
S	NULL
and	NULL
McDonne	NULL
TJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
11	NULL
,	NULL
175-179	NULL
.	NULL

Hurlin	NULL
PJ	NULL
,	NULL
Queva	NULL
C	NULL
,	NULL
Koskinen	NULL
PJ	NULL
,	NULL
Steingrimsson	NULL
E	NULL
,	NULL
Ayer	NULL
DE	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Jenkin	NULL
NA	NULL
,	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
5646-5659	NULL
.	NULL

Jansen-Duerr	NULL
P	NULL
,	NULL
Meichle	NULL
A	NULL
,	NULL
Steiner	NULL
P	NULL
,	NULL
Pagano	NULL
M	NULL
,	NULL
Finke	NULL
K.	NULL
,	NULL
Botz	NULL
J	NULL
,	NULL
Wessbecher	NULL
J	NULL
,	NULL
Dracetta	NULL
G	NULL
and	NULL
Eilers	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
3685-3689	NULL
.	NULL

Juin	NULL
P	NULL
,	NULL
Hueber	NULL
AO	NULL
,	NULL
Littlewood	NULL
T	NULL
and	NULL
Evan	NULL
G.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
13	NULL
,	NULL
1367-1381	NULL
.	NULL

Keath	NULL
EJ	NULL
,	NULL
Caimi	NULL
PG	NULL
and	NULL
Cole	NULL
MD	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
39	NULL
,	NULL
339	NULL
348	NULL
.	NULL

Kiermaier	NULL
A	NULL
and	NULL
Eilers	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
505-507	NULL
.	NULL

Lahoz	NULL
EG	NULL
,	NULL
Xu	NULL
L	NULL
,	NULL
Schreiber-Agus	NULL
,	NULL
N	NULL
and	NULL
DePinho	NULL
RA	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
5503-5507	NULL
.	NULL

Analysis	NULL
of	NULL
Mad1	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
using	NULL
Ick-Mad1	NULL
transgenic	NULL
mice	NULL
B	NULL
Rudolph	NULL
et	NULL
al	NULL
a	NULL
Larsson	NULL
LG	NULL
,	NULL
Petterson	NULL
M	NULL
,	NULL
Oberg	NULL
F	NULL
,	NULL
Nilson	NULL
K	NULL
and	NULL
Luescher	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
1247-1252	NULL
.	NULL

Lindeman	NULL
GJ	NULL
,	NULL
Harris	NULL
AW	NULL
,	NULL
Bath	NULL
ML	NULL
,	NULL
Eisenman	NULL
RN	NULL
and	NULL
Adams	NULL
JM	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
1013-1017	NULL
.	NULL

Linette	NULL
GP	NULL
,	NULL
Li	NULL
Y	NULL
,	NULL
Roth	NULL
K	NULL
and	NULL
Korsmeyer	NULL
SJ	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
,	NULL
9545-9552	NULL
.	NULL

Lyons	NULL
AB	NULL
and	NULL
Parish	NULL
CR	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
171	NULL
,	NULL
131-137	NULL
.	NULL

Moore	NULL
JP	NULL
,	NULL
Hancock	NULL
DC	NULL
,	NULL
Littlewood	NULL
TD	NULL
and	NULL
Evan	NULL
GI	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
2	NULL
,	NULL
65-80	NULL
.	NULL

Queva	NULL
C	NULL
,	NULL
Hurlin	NULL
PJ	NULL
,	NULL
Kevin	NULL
PF	NULL
and	NULL
Eisenman	NULL
RN	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
16	NULL
,	NULL
967-977	NULL
.	NULL

Roussel	NULL
MF	NULL
,	NULL
Ashmun	NULL
RA	NULL
,	NULL
Sherr	NULL
CJ	NULL
,	NULL
Eisenman	NULL
RN	NULL
and	NULL
Ayer	NULL
DE	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
2796-2801	NULL
.	NULL

Rudolph	NULL
B	NULL
,	NULL
Hueber	NULL
AO	NULL
and	NULL
Evan	NULL
GI	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
19	NULL
,	NULL
1891-1900	NULL
.	NULL

Rudolph	NULL
B	NULL
,	NULL
Saffrich	NULL
R	NULL
,	NULL
Zwicker	NULL
J	NULL
,	NULL
Henglein	NULL
B	NULL
,	NULL
Mueller	NULL
R	NULL
,	NULL
Ansorge	NULL
W	NULL
and	NULL
Eilers	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
3065-3076	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
and	NULL
Maniatis	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Molecular	NULL
Cloning	NULL
,	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Second	NULL
Edition	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
.	NULL

Schreiber-Agus	NULL
N	NULL
,	NULL
Meng	NULL
Y	NULL
,	NULL
Hoang	NULL
T	NULL
,	NULL
Harry	NULL
HJ	NULL
,	NULL
Chen	NULL
K	NULL
,	NULL
Greenberg	NULL
R	NULL
,	NULL
Cordon-Cardo	NULL
C	NULL
,	NULL
Lee	NULL
HW	NULL
and	NULL
DePinho	NULL
RA	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
393	NULL
,	NULL
483-487	NULL
.	NULL

Schwartz	NULL
D	NULL
and	NULL
Rotter	NULL
V.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Sem	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
325	NULL
336	NULL
.	NULL

Spanopoulou	NULL
E	NULL
,	NULL
Early	NULL
A	NULL
,	NULL
Elliot	NULL
J	NULL
,	NULL
Crispe	NULL
N	NULL
,	NULL
Ladyman	NULL
H	NULL
,	NULL
Ritter	NULL
M	NULL
,	NULL
Watt	NULL
S	NULL
,	NULL
Grosveld	NULL
F	NULL
and	NULL
Kioussis	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
342	NULL
,	NULL
185-189	NULL
.	NULL

Steiner	NULL
P	NULL
,	NULL
Philipp	NULL
A	NULL
,	NULL
Lukas	NULL
J	NULL
,	NULL
Godden	NULL
Kent	NULL
D	NULL
,	NULL
Pagano	NULL
M	NULL
,	NULL
Mittnacht	NULL
S	NULL
,	NULL
Bartek	NULL
J	NULL
and	NULL
Eilers	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
481-426	NULL
.	NULL

Stewart	NULL
M	NULL
,	NULL
Cameron	NULL
E	NULL
,	NULL
Campbell	NULL
M	NULL
,	NULL
Mcfarlane	NULL
R	NULL
,	NULL
Toth	NULL
S	NULL
,	NULL
Lang	NULL
K	NULL
,	NULL
Onions	NULL
D	NULL
and	NULL
Neil	NULL
JC	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
53	NULL
,	NULL
1023-1030	NULL
.	NULL

Teh	NULL
HS	NULL
,	NULL
Kishi	NULL
H	NULL
,	NULL
Scott	NULL
B	NULL
and	NULL
von	NULL
Bochmer	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
169	NULL
,	NULL
795-806.	NULL
von	NULL
Boehmer	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
531-556	NULL
.	NULL

Wagner	NULL
AJ	NULL
,	NULL
Kokontis	NULL
JM	NULL
and	NULL
Hay	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
2817-2830	NULL
.	NULL

Wells	NULL
AD	NULL
,	NULL
Gudmundsdottir	NULL
H	NULL
and	NULL
Turka	NULL
LA	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
100	NULL
,	NULL
3173-3183	NULL
.	NULL

Wildin	NULL
RS	NULL
,	NULL
Garvin	NULL
A	NULL
,	NULL
Pawar	NULL
M	NULL
,	NULL
Lewis	NULL
SD	NULL
,	NULL
Abraham	NULL
KM	NULL
,	NULL
Forbusch	NULL
KA	NULL
,	NULL
Ziegler	NULL
SF	NULL
,	NULL
Allen	NULL
JM	NULL
and	NULL
Perlmutter	NULL
RM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
173	NULL
,	NULL
383-393	NULL
.	NULL

Zervos	NULL
AS	NULL
,	NULL
Gyuris	NULL
J	NULL
and	NULL
Brent	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
72	NULL
,	NULL
223-232	NULL
.	NULL

Zoernig	NULL
M	NULL
,	NULL
Hueber	NULL
AO	NULL
and	NULL
Evan	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
467-470	NULL
.	NULL

1175	NULL
Oncogene	NULL

